Processing 00000000.tx.1: Mutant Neuroserpin (S49P) That Causes Familial Encephalopathy with Neuroserpin Inclusion Bodies Is a Poor Proteinase Inhibitor and Readily Forms Polymers in Vitro* Didier Belorgey, Damian C. 

Phrase: "Mutant Neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "That"

Phrase: "Causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Familial Encephalopathy with Neuroserpin Inclusion Bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "Is"

Phrase: "a Poor Proteinase Inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C2673177:proteinase inhibitor [Molecular Function]
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "Readily"

Phrase: "Forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "Polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "in Vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "* Didier Belorgey,"

Phrase: "Damian C."
Processing 00000000.tx.2: Crowther, Ravi Mahadeva, and David A. 

Phrase: "Crowther,"

Phrase: "Ravi Mahadeva,"

Phrase: "and"

Phrase: "David A."
Processing 00000000.tx.3: Lomas From the Respiratory Medicine Unit and Neurology Unit, Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/Medical Research Council Building, Hills Road, Cambridge CB2 2XY, United Kingdom Received for publication, January 22,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Familial encephalopathy with neuroserpin inclusion bodies (FENIB) is an autosomal dominant dementia that is characterized by intraneuronal inclusions of mutant neuroserpin. 

Phrase: "Lomas From the Respiratory Medicine Unit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1018105:Lomas [Fungus]

Phrase: "and"

Phrase: "Neurology Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Cambridge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Cambridge Institute for Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Wellcome Trust/Medical Research Council Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1547706:Building [Functional Concept]
   799   C1999269:Building [Manufactured Object]

Phrase: "Hills Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Cambridge CB2 2XY,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 22,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Familial encephalopathy with neuroserpin inclusion bodies (FENIB)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "is"

Phrase: "an autosomal dominant dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   734   C0443147:Autosomal dominant [Intellectual Product]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "that"

Phrase: "is"

Phrase: "characterized by intraneuronal inclusions of mutant neuroserpin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3553502:Intraneuronal inclusions [Finding]
   748   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1418546:NEUROSERPIN [Gene or Genome]
   748   C1880022:Characterized [Activity]
   714   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.4: We report here the expression, purification, and characterization of wild-type neuroserpin and neuroserpin containing the S49P mutation that causes FENIB. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "the expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of wild-type neuroserpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the S49P mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "FENIB."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]
Processing 00000000.tx.5: Wild-type neuroserpin formed SDS-stable complexes with tPA with an association rate constant and Ki of 1.2104 M1s1 and 5.8nM, respectively. 

Phrase: "Wild-type neuroserpin formed SDS-stable complexes with tPA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1704241:Complexes [Chemical Viewed Structurally]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "with an association rate constant"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C2986811:Rate Constant [Quantitative Concept]
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "and"

Phrase: "Ki of 1.2104 M1s1"

Phrase: "and"

Phrase: "5.8nM,"

Phrase: "respectively."
Processing 00000000.tx.6: In contrast, S49P neuroserpin formed unstable complexes with an association rate constant and Ki of 0.3104 M1s1 and 533.3nM, respectively. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "S49P neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "unstable complexes with an association rate constant"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "Ki of 0.3104 M1s1"

Phrase: "and"

Phrase: "533.3nM,"

Phrase: "respectively."
Processing 00000000.tx.7: An assessment by circular dichroism showed that S49P neuroserpin had a lower melting temperature than wild-type protein (49.9and 56.6C, respectively) and more readily formed loop-sheet polymers under physiological conditions. 

Phrase: "An assessment by circular dichroism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that S49P neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "had"

Phrase: "a lower melting temperature than wild-type protein"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0005903:temperature [Organism Attribute]
   744   C0039476:*Temperature [Quantitative Concept]
   744   C0599882:Melting [Natural Phenomenon or Process]
   711 E C0050572:MELT [Therapeutic or Preventive Procedure]
   711 E C1540179:MELT [Gene or Genome]

Phrase: "(49.9and 56.6C,"

Phrase: "respectively"

Phrase: ")"

Phrase: "and"

Phrase: "more readily formed loop-sheet polymers under physiological conditions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
Processing 00000000.tx.8: Neither the wild-type nor S49P neuroserpin accepted the P7-P2 1-anti-trypsin or P14-P3 antithrombin-reactive loop peptides that have been shown to block polymer formation in other members of the serpin superfamily. 

Phrase: "Neither"

Phrase: "the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "nor"

Phrase: "S49P neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "the P7-P2 1-anti-trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "P14-P3 antithrombin-reactive loop peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   859   C1451273:P3 peptide [Amino Acid, Peptide, or Protein]
   799   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "polymer formation in other members of the serpin superfamily."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]
Processing 00000000.tx.9: Taken together, these data demonstrate that S49P neuroserpin is a poor proteinase inhibitor and readily forms loop-sheet polymers. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that S49P neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "is"

Phrase: "a poor proteinase inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C2673177:proteinase inhibitor [Molecular Function]
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "readily"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "loop-sheet polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   721 E C1218520:Polymeria [Plant]
Processing 00000000.tx.10: These findings provide strong support for the role of neuroserpin polymerization in the formation of the intraneuronal inclusions that are characteristic of FENIB.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong support for the role of neuroserpin polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0183683:Support [Medical Device]
   744   C1521721:Support [Conceptual Entity]

Phrase: "in the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of the intraneuronal inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3553502:Intraneuronal inclusions [Finding]
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "characteristic of FENIB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521970:Characteristic [Qualitative Concept]
   743   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES An increasing number of neurodegenerative disorders are recognized to result from the aggregation of proteins within the tissues of the central nervous system (1-3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "An increasing number of neurodegenerative disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "recognized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result from the aggregation of proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "within the tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "of the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(1-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: In conditions such as Alzheimer's disease, Huntington's disease, and the prion encephalopathies, the protein deposition is associated with a conformational transition within the protein and aberrant -strand linkage. 

Phrase: "In conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "such as Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Huntington's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the prion encephalopathies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085584:Encephalopathies [Disease or Syndrome]
   827 E C1963101:Encephalopathy [Finding]

Phrase: "the protein deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333584:Protein deposition [Pathologic Function]
   861   C0333562:Deposition [Functional Concept]

Phrase: "is"

Phrase: "associated with a conformational transition"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0599156:Transition [Cell or Molecular Dysfunction]
   760   C2700061:Transition [Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "within the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "aberrant -strand linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023745:linkage [Molecular Function]
Processing 00000000.tx.13: Indeed, these and other disorders have now been grouped together as a new class of conditions, the conformational diseases (4-6). 

Phrase: "Indeed,"

Phrase: "these"

Phrase: "and"

Phrase: "other disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "grouped"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0439745:Grouped [Spatial Concept]
   966 E C0441833:Group [Idea or Concept]
   966 E C0687744:group [Population Group]
   966 E C1257890:Group [Population Group]
   966 E C1552516:Group [Health Care Related Organization]
   966 E C1705428:Group [Conceptual Entity]
   966 E C1705429:Group [Population Group]

Phrase: "together as a new class of conditions,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205314:New [Temporal Concept]
   748   C0456387:Class [Intellectual Product]
   748   C1705943:Class [Classification]
   748   C1883357:Together [Qualitative Concept]
   714   C0012634:condition [Disease or Syndrome]
   714   C0348080:Condition [Qualitative Concept]
   714   C1705253:Condition [Conceptual Entity]

Phrase: "the conformational diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(4-6"

Phrase: ")."
Processing 00000000.tx.14: Our understanding of the mechanisms underlying these neurodegenerative diseases has been enhanced by the recent description of a new dementia, familial encephalopathy with neuroserpin inclusion bodies (FENIB)1 (7, 8). 

Phrase: "Our understanding of the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "underlying"

Phrase: "these neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "enhanced by the recent description of a new dementia,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0205314:New [Temporal Concept]
   742   C0332185:Recent [Temporal Concept]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C0678257:Description [Idea or Concept]
   742   C2349975:Enhanced [Activity]

Phrase: "familial encephalopathy with neuroserpin inclusion bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "(FENIB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.15: FENIB is characterized by the accumulation of neuroserpin as periodic acid-Schiff-positive diastase-resistant inclusions or Collins' bodies within the deep layers of the cerebral cortex. 

Phrase: "FENIB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "is"

Phrase: "characterized by the accumulation of neuroserpin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1418546:NEUROSERPIN [Gene or Genome]
   753   C1880022:Characterized [Activity]

Phrase: "as periodic acid-Schiff-positive diastase-resistant inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1512693:Inclusion [Qualitative Concept]

Phrase: "or"

Phrase: "Collins' bodies within the deep layers of the cerebral cortex."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0242821:bodies [Human]
   739   C1995017:Bodies [Cell Component]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.16: The original FENIB kindred presented with presenile dementia and cognitive deficits that are unlike those of Alzheimer's or Huntington's disease (7-10). 

Phrase: "The original FENIB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   744   C0085584:Encephalopathy [Disease or Syndrome]
   744   C1963101:Encephalopathy [Finding]

Phrase: "kindred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindred [Qualitative Concept]

Phrase: "presented with presenile dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   770   C0449450:Presented [Idea or Concept]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "cognitive deficits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "that"

Phrase: "are unlike those of Alzheimer's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1551058:Are [Quantitative Concept]

Phrase: "or"

Phrase: "Huntington's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(7-10"

Phrase: ")."
Processing 00000000.tx.17: A genetic analysis of two families with FENIB revealed point mutations in helix B of the neuron-specific protein, neuroserpin (8). 

Phrase: "A genetic analysis of two families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with FENIB"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0007637:Inclusion Bodies [Cell Component]
   795   C0015576:familial [Family Group]
   795   C0085584:Encephalopathy [Disease or Syndrome]
   795   C0241888:Familial [Functional Concept]
   795   C0242821:bodies [Human]
   795   C0332287:With [Qualitative Concept]
   795   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C1418546:NEUROSERPIN [Gene or Genome]
   795   C1512693:Inclusion [Qualitative Concept]
   795   C1705690:With [Intellectual Product]
   795   C1963101:Encephalopathy [Finding]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
   724 E C1704727:Family [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "point mutations in helix B of the neuron-specific protein,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   757   C2924613:Point B [Body Location or Region]
   739   C0026882:Mutations [Genetic Function]
   739   C1552961:Point [Quantitative Concept]
   739   C2347617:point [Quantitative Concept]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.18: Neuroserpin is an axonally secreted member of the serine proteinase inhibitor or serpin superfamily (11-15). 

Phrase: "Neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "is"

Phrase: "an axonally secreted member of the serine proteinase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "or"

Phrase: "serpin superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036763:Serpin Superfamily [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1883220:Superfamily [Conceptual Entity]

Phrase: "(11-15"

Phrase: ")."
Processing 00000000.tx.19: Members of this family share a similar molecular architecture based on a dominant -sheet A and a mobile inhibitory reactive center loop (16). 

Phrase: "Members of this family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   819   C0086282:Family Members [Family Group]
   802 E C1611821:Family Member [Intellectual Product]
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a similar molecular architecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003737:Architecture [Occupation or Discipline]

Phrase: "based on a dominant -sheet A"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C1527178:Based [Functional Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2349187:Sheet [Quantitative Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "a mobile inhibitory reactive center loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205099:Center [Spatial Concept]
   804   C0205332:Reactive [Qualitative Concept]
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.20: The reactive center loop presents a peptide substrate to the target proteinase. 

Phrase: "The reactive center loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205099:Center [Spatial Concept]
   827   C0205332:Reactive [Qualitative Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a peptide substrate to the target proteinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.21: Following docking, the reactive loop is cleaved, and the proteinase is inhibited by translocation over 70to the lower pole of the inhibitor (16, 17). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "docking,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0442632:docking [Manufactured Object]
  1000   C1522290:Docking [Molecular Function]
   966 E C0330386:Dock [Plant]

Phrase: "the reactive loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "is"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: ","

Phrase: "and"

Phrase: "the proteinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1622131:proteinase [Molecular Function]
  1000   C1947941:Proteinase [Enzyme]

Phrase: "is"

Phrase: "inhibited by translocation"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C2987521:Translocation [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "over 70to"

Phrase: "the lower pole of the inhibitor"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0441994:Lower [Spatial Concept]
   753   C0935623:Pole [Body Location or Region]
   753   C1418729:POLE [Gene or Genome]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]
   719 E C0205251:low [Qualitative Concept]
   719 E C1299352:Low [Qualitative Concept]
   719 E C1550472:low [Idea or Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.22: The most probable target for neuroserpin is tissue plasminogen activator (tPA) (13, 18, 19), and it has been suggested that neuroserpin-tPA interactions play an important role in regulating neuronal and synaptic plasticity and memory (20-27). 

Phrase: "The most probable target for neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "is"

Phrase: "tissue plasminogen activator (tPA)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "(13,"

Phrase: "18,"

Phrase: "19"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that neuroserpin-tPA interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C1514153:Plasminogen Activator Interaction [Molecular Function]
   771   C1704675:Interaction [Functional Concept]
   717   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   717   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "synaptic plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(20-27"

Phrase: ")."
Processing 00000000.tx.23: The "mousetrap" mechanism is central to the inhibitory function of the serpins but renders them susceptible to mutations that facilitate aberrant conformational change (16). 

Phrase: "The ""mousetrap"" mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "central to the inhibitory function of the serpins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205099:Central [Spatial Concept]
   744   C1879652:Central - [Laboratory Procedure]

Phrase: "but"

Phrase: "renders"

Phrase: "them susceptible to mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "that"

Phrase: "facilitate"

Phrase: "aberrant conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0301641:Conformational change [Molecular Function]
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.24: This process is best characterized for the serpin 1-antitrypsin (28, 29). 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "characterized for the serpin 1-antitrypsin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418544:ANTITRYPSIN [Gene or Genome]
   753   C1880022:Characterized [Activity]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.25: Point mutations of 1-antitrypsin perturb the relationship between the reactive center loop and -sheet A.

Phrase: "Point mutations of 1-antitrypsin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   760   C0026882:Mutations [Genetic Function]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "perturb"

Phrase: "the relationship between the reactive center loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and -"

Phrase: "sheet A."
Processing 00000000.tx.26: This allows the sequential incorporation of the reactive loop of one molecule into -sheet A of another to form chains of polymers that are retained within hepatocytes (30-32). 

Phrase: "This"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the sequential incorporation of the reactive loop of one molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0243126:incorporation [Functional Concept]

Phrase: "into -sheet A"

Phrase: "of another to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "chains of polymers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0337112:chains [Manufactured Object]
   790   C1524075:Chains [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "retained within hepatocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0227525:Hepatocytes [Cell]
   790   C0333118:Retained [Functional Concept]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(30-32"

Phrase: ")."
Processing 00000000.tx.27: These polymers tangle to form periodic acid-Schiff-positive, diastase-resistant inclusions that are associated with neonatal hepatitis, juvenile cirrhosis, and hepatocellular carcinoma (33). 

Phrase: "These polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "tangle"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "periodic acid-Schiff-positive, diastase-resistant inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1512693:Inclusion [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "associated with neonatal hepatitis,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0027613:Neonatal hepatitis [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0019158:Hepatitis [Disease or Syndrome]
   770   C0019159:hepatitis [Disease or Syndrome]
   770   C0795623:hepatitis [Immunologic Factor,Pharmacologic Substance]
   770   C1552240:Neonatal [Professional or Occupational Group]
   770   C1552264:Neonatal [Professional or Occupational Group]
   770   C2939425:Neonatal [Temporal Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "juvenile cirrhosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0023890:Cirrhosis [Disease or Syndrome]
   861   C1623038:Cirrhosis [Disease or Syndrome]
   789 E C0439686:Cirrhotic [Qualitative Concept]

Phrase: "and"

Phrase: "hepatocellular carcinoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512411:Hepatocellular carcinoma [Neoplastic Process]
  1000   C2239176:Carcinoma, Hepatocellular [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]
   861   C2697585:Hepatocellular [Qualitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.28: It was very striking that the mutations that underlie FENIB were in the same shutter domain of the serpin molecule as those that caused polymerization of 1-antitrypsin with accompanying liver disease (8, 34). 

Phrase: "It"

Phrase: "was"

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "striking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038452:striking [Occupational Activity]

Phrase: "that"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "underlie"

Phrase: "FENIB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "were in the same shutter domain of the serpin molecule"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0445247:Same [Qualitative Concept]
   739   C0567416:Molecule [Substance]
   739   C1710078:Shutter [Manufactured Object]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
   722   C0599845:molecular domain [Molecular Function]

Phrase: "as those"

Phrase: "that caused polymerization of 1-antitrypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "with accompanying liver disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0023895:Liver disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(8,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.29: Indeed, the examination of protein from the brains of affected individuals demonstrated that the inclusions were composed solely of mutant neuroserpin and that this had formed chains of loop-sheet polymers identical to those of mutant 1-antitrypsin, which accumulate within the liver (8, 9, 35). 

Phrase: "Indeed,"

Phrase: "the examination of protein"

Phrase: "from the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of affected individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "were"

Phrase: "composed"

Phrase: "solely of mutant neuroserpin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "had"

Phrase: "formed chains of loop-sheet polymers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337112:chains [Manufactured Object]
   753   C1524075:Chains [Idea or Concept]

Phrase: "identical to those of mutant 1-antitrypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205280:Identical [Qualitative Concept]

Phrase: "which"

Phrase: "accumulate within the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "(8,"

Phrase: "9,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.30: Thus, it seems likely that the accumulation of neuroserpin polymers within the brain causes neuronal loss and hence dementia. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the accumulation of neuroserpin polymers"

Phrase: "within the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "hence dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.31: However, there is evidence that neuroserpin is neuroprotective (36), and that a shift in the balance between plasminogen and plasmin balance can also cause neuronal cell death (37). 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "is"

Phrase: "neuroprotective"

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that"

Phrase: "a shift in the balance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333051:Shift [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]

Phrase: "between plasminogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "and"

Phrase: "plasmin balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014653:Balance [Organism Function]
   861   C0205415:Balance [Functional Concept]
   861   C0560184:Balance [Finding]

Phrase: "can"

Phrase: "also"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2754100:neuronal cell death [Cell Function]
           neuron death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.32: Moreover, it is impossible to predict whether the shutter domain mutants retain inhibitory activity. 

Phrase: "Moreover,"

Phrase: "it"

Phrase: "is"

Phrase: "impossible to"

Phrase: "predict"

Phrase: "whether"

Phrase: "the shutter domain mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "inhibitory activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.33: We report here the expression, purification, and characterization of wild-type neuroserpin and neuroserpin containing the S49P mutation that underlies FENIB. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "the expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of wild-type neuroserpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the S49P mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "underlies"

Phrase: "FENIB."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]
Processing 00000000.tx.34: We show that S49P neuroserpin is not effective as a proteinase inhibitor and rapidly forms polymers under physiological conditions.  

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that S49P neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "is"

Phrase: "not effective as a proteinase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: "and"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "polymers under physiological conditions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs (Hitchin, UK), and oligonucleotides were synthesized by Invitrogen (Paisley, UK). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "Restriction enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   861   C0443288:Restriction [Functional Concept]

Phrase: "and"

Phrase: "T4 DNA ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039213:T4 DNA Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0208356:DNA ligase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "purchased from New England Biolabs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027965:New England [Geographic Area]
   760   C0014282:England [Geographic Area]
   760   C0205314:New [Temporal Concept]
   760   C0869011:purchased [Activity]

Phrase: "(Hitchin,"

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized by Invitrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:Synthesized [Activity]

Phrase: "(Paisley,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.36: The expression vector pQE31 was from Qiagen (Crawley, UK). 

Phrase: "The expression vector pQE31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was from Qiagen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(Crawley,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.37: Ampicillin, kanamycin, and isopropyl--D-thiogalactopyranoside were from Melford Laboratories Ltd. 

Phrase: "Ampicillin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0002680:Ampicillin [Antibiotic,Organic Chemical]
   944 E C0700944:Polycillin [Antibiotic,Organic Chemical]
   944 E C0700946:Omnipen [Antibiotic,Organic Chemical]

Phrase: "kanamycin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022487:Kanamycin [Antibiotic,Carbohydrate]
   944 E C0022491:Kantrex [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "isopropyl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "thiogalactopyranoside"

Phrase: "were from Melford Laboratories Ltd."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1136140:LTD [Organ or Tissue Function]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.38: (Ipswich, UK). 

Phrase: "(Ipswich,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.39: HiTrap chelating HP and HiTrap Q-Sepharose were from Amersham Biosciences. 

Phrase: "HiTrap chelating HP"

Phrase: "and"

Phrase: "HiTrap Q-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Sepharose [Carbohydrate]

Phrase: "were from Amersham Biosciences."
Processing 00000000.tx.40: The tPA substrate S-2288 (H-D-Ile-Pro-Arg-para-nitroanilide) was from Chromogenix (Quadratech, Epsom, UK). 

Phrase: "The tPA substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1710236:Substrate [Manufactured Object]
   756   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]

Phrase: "S-"

Phrase: "2288"

Phrase: "(H-D-Ile-Pro-Arg-para-nitroanilide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030563:Para [Finding]

Phrase: ")"

Phrase: "was from Chromogenix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(Quadratech,"

Phrase: "Epsom,"

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.41: 1,5-Dansyl-Glu-Gly-Arg-chloromethylketone and tPA were from Calbiochem. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5-Dansyl-Glu-Gly-Arg-chloromethylketone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   947   C0057126:dansyl-Glu-Gly-Arg-chloromethyl ketone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "were from Calbiochem."
Processing 00000000.tx.42: Unless otherwise stated, all experiments were carried out in a solution referred to as the buffer (50mM Tris-HCl, 50mM KCl, pH 7.4). 

Phrase: "Unless"

Phrase: "otherwise"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: ","

Phrase: "all experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0439787:Out [Spatial Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C0849355:Out [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as the buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1883351:To [Qualitative Concept]

Phrase: "(50mM Tris-HCl,"

Phrase: "50mM KCl,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.43: Synthetic peptides corresponding to the P7-P22 sequence of the reactive center loop of 1-antitrypsin (FLEAIG) and P14-P3 sequence of antithrombin (SEAAASTAVVIA) were synthesized and purified by Genosys Biotechnologies Inc. 

Phrase: "Synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "corresponding to the P7-P22 sequence of the reactive center loop"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205099:Center [Spatial Concept]
   738   C0205332:Reactive [Qualitative Concept]
   738   C0419518:Loop [Medical Device]
   738   C0445022:Loop [Spatial Concept]
   738   C1424742:p7 [Gene or Genome]
   738   C1519249:Sequence [Functional Concept]
   738   C1538631:p22 [Gene or Genome]
   738   C1825005:p22 [Gene or Genome]
   738   C1846989:p22 [Gene or Genome]

Phrase: "of 1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "(FLEAIG"

Phrase: ")"

Phrase: "and"

Phrase: "P14-P3 sequence of antithrombin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "(SEAAASTAVVIA"

Phrase: ")"

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "purified by Genosys Biotechnologies Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnologies [Biomedical Occupation or Discipline]
   760   C1998793:Purified [Functional Concept]
Processing 00000000.tx.44: (Cambridge, UK) and MWB (Cambridge, UK), respectively. 

Phrase: "(Cambridge,"

Phrase: "UK"

Phrase: ")"

Phrase: "and"

Phrase: "MWB"

Phrase: "(Cambridge,"

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.45: They were dissolved in 50mM Tris-HCl, pH 7.4,and water, respectively. 

Phrase: "They"

Phrase: "were"

Phrase: "dissolved in 50mM Tris-HCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0450400:50mm [Quantitative Concept]
   760   C0814229:TRI [Intellectual Product]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.46: Construction and Mutagenesis of Expression Plasmids-- The pUAST vector containing the cDNA for human neuroserpin was kindly provided by Dr. 

Phrase: "Construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Mutagenesis of Expression Plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079866:Mutagenesis [Molecular Function]
   770   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "The pUAST vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the cDNA for human neuroserpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.47: Clare Green (Department of Genetics, University of Cambridge, UK). 

Phrase: "Clare Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "(Department of Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587466:Genetics department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "University of Cambridge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.48: Neuroserpin was amplified by the polymerase chain reaction and inserted into the expression vector pQE31 by the restriction sites BamHI and KpnI. 

Phrase: "Neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "was"

Phrase: "amplified by the polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "inserted into the expression vector pQE31"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441587:Inserted [Health Care Activity]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "by the restriction sites BamHI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1882940:Restriction Site [Nucleotide Sequence]

Phrase: "and"

Phrase: "KpnI."
Processing 00000000.tx.49: The S49P mutation was introduced by a two-step polymerase chain reaction. 

Phrase: "The S49P mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "introduced by a two-step polymerase chain reaction."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0205448:Two [Quantitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1261552:Step [Conceptual Entity]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524075:Chain [Idea or Concept]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C2825408:Step [Manufactured Object]
   711   C1292748:introduce [Functional Concept]
Processing 00000000.tx.50: The sequence of the wild-type and mutant neuroserpin was confirmed by DNA sequencing of the entire neuroserpin gene. 

Phrase: "The sequence of the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "mutant neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "was"

Phrase: "confirmed by DNA sequencing of the entire neuroserpin gene."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   764   C0162326:DNA sequencing [Nucleotide Sequence]
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   764   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   762   C1294197:Gene Sequencing [Laboratory Procedure]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017337:Gene [Gene or Genome]
   742   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0439751:Entire [Quantitative Concept]
   742   C0444667:Entire [Quantitative Concept]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1418546:NEUROSERPIN [Gene or Genome]
   742   C1553778:Sequencing [Intellectual Product]
   742   C1561491:Sequencing [Functional Concept]
   708 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.51: Recombinant proteins were expressed with a six-histidine tag at the N terminus. 

Phrase: "Recombinant proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "were"

Phrase: "expressed with a six-histidine tag"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C0205452:Six [Quantitative Concept]
   753   C1710492:TAG [Gene or Genome]

Phrase: "at the N terminus."
Processing 00000000.tx.52: Expression and Purification of Recombinant Proteins-- Escherichia coli were transformed with the plasmid containing wild-type and mutant neuroserpin, and the proteins expressed as described previously for 1-antitrypsin (38). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Purification of Recombinant Proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0597301:protein purification [Laboratory Procedure]
   770   C0243114:purification [Functional Concept]
   770   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014834:Escherichia coli [Bacterium]
   861   C0014833:Escherichia [Bacterium]

Phrase: "were"

Phrase: "transformed with the plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1510411:Transformed [Pathologic Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant neuroserpin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for 1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.53: The cells were harvested by centrifugation, resuspended in buffer A (50mM Tris-HCl, 100mM NaCl, 10mM EDTA, pH 7.8), and disrupted by sonication. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested by centrifugation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "resuspended in buffer A (50mM Tris-HCl,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0450400:50mm [Quantitative Concept]
   748   C0814229:TRI [Intellectual Product]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "disrupted by sonication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0037680:Sonication [Research Activity]
   790   C0332454:Disrupted [Qualitative Concept]
Processing 00000000.tx.54: The cell pellet was washed three times with buffer A containing 0.05% v/v Triton X-100 and once again with buffer A alone prior to solubilization in 10mM Tris-HCl, 100mM NaH2PO4, 6M guanidinium-HCl, pH 8.0.

Phrase: "The cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "A containing 0.05% v/v Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   812   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   793   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "once"

Phrase: "again with buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "A alone prior to solubilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205171:Alone [Quantitative Concept]
   760   C0439044:alone [Finding]
   760   C0679994:alone [Group Attribute]

Phrase: "in 10mM Tris-HCl,"

Phrase: "100mM NaH2PO4,"

Phrase: "6M guanidinium-HCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120446:Guanidinium [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "pH 8.0."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.55: The protein was then refolded drop by drop overnight at 4C in 20mM Na2HPO4, 100mM NaCl, pH 7.8.

Phrase: "The protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "then refolded drop by drop overnight"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in 20mM Na2HPO4,"

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.8."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.56: This solution was loaded onto a HiTrap chelating column precharged with 0.1M NiSO4. 

Phrase: "This solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "loaded onto a HiTrap chelating column"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1708715:Loaded [Activity]
   753   C3537131:Chelating [Molecular Function]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "precharged with 0.1M NiSO4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470296:1M [Quantitative Concept]
Processing 00000000.tx.57: The bound protein was eluted as a single peak with an imidazole gradient (0-0.3 M). 

Phrase: "The bound protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "eluted as a single peak"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0444505:Peak [Quantitative Concept]

Phrase: "with an imidazole gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "(0-0.3"

Phrase: "M)."
Processing 00000000.tx.58: The fractions were collected, dialyzed against buffer B (20mM Tris-HCl, 20mM NaCl, pH 7.4), and loaded onto a HiTrap Q-Sepharose column. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "dialyzed against buffer B (20mM Tris-HCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]

Phrase: "20mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "loaded onto a HiTrap Q-Sepharose column."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0036681:Sepharose [Carbohydrate]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.59: The bound protein was eluted with a NaCl gradient (0-1 M), dialyzed against 50mM Tris-HCl, 50mM KCl, pH 7.4,concentrated, and then stored at 70C. 

Phrase: "The bound protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "eluted with a NaCl gradient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "(0-1"

Phrase: "M)"

Phrase: ","

Phrase: "dialyzed against 50mM Tris-HCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0450400:50mm [Quantitative Concept]
   760   C0814229:TRI [Intellectual Product]

Phrase: "50mM KCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stored at 70C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.60: Purified neuroserpin migrated as a single band on SDS-PAGE and >90% was in a monomeric form when assessed by nondenaturing and transverse urea gradient PAGE (39). 

Phrase: "Purified neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "migrated as a single band"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0175723:Band [Medical Device]
   760   C0205171:Single [Quantitative Concept]
   760   C0232902:Migrated [Functional Concept]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "on SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and >"

Phrase: "90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "was in a monomeric form"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1421478:WAS [Gene or Genome]
   760   C1522492:Form [Functional Concept]

Phrase: "when"

Phrase: "assessed by nondenaturing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "transverse urea gradient PAGE (39"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   804   C0205106:Transverse [Spatial Concept]
   804   C0439182:% gradient [Quantitative Concept]
   804   C0446380:Transverse [Spatial Concept]
   804   C0812409:Gradient [Quantitative Concept]
   804   C1704732:Page [Intellectual Product]
   748 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.61: Complex Formation Assays-- Wild-type neuroserpin (NS) and mutant neuroserpin (NS(S49P)) were incubated with varying amounts of tPA at 25C. 

Phrase: "Complex Formation Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "--"

Phrase: "Wild-type neuroserpin (NS)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1418546:NEUROSERPIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "mutant neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ")"

Phrase: "were"

Phrase: "incubated with varying amounts of tPA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   800   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   770   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0040300:Tissue [Tissue]
   744   C1265611:amounts [Quantitative Concept]
   744   C1367553:PLASMINOGEN [Gene or Genome]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1547928:Tissue [Intellectual Product]

Phrase: "at 25C."
Processing 00000000.tx.62: Samples were taken at different time intervals, and the reaction was stopped by the addition of 1mM 1,5-dansyl-Glu-Gly-Arg-chloromethylketone (final concentration) to inhibit any free tPA (40). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "taken at different time intervals,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   773   C0872291:Time Interval [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   760   C3541383:Time [Temporal Concept]
   726 E C1515187:Take [Health Care Activity]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 1mM 1,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: "5-dansyl-Glu-Gly-Arg-chloromethylketone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   947   C0057126:dansyl-Glu-Gly-Arg-chloromethyl ketone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "any free tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.63: The samples were then mixed with SDS-PAGE loading buffer, snap-frozen in liquid nitrogen, and stored until the completion of the experiment. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "mixed with SDS-PAGE loading buffer,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0205430:Mixed [Functional Concept]
   753   C1704732:Page [Intellectual Product]
   753   C1708715:Loading [Activity]
   753   C3160715:Mixed [Finding]
   719 E C1421951:MIX [Gene or Genome]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]
   719 E C1720722:Mix [Qualitative Concept]

Phrase: "snap-"

Phrase: "frozen in liquid nitrogen,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "stored until the completion of the experiment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205197:Completion [Qualitative Concept]
   748   C0681814:Experiment [Research Activity]
   748   C1554962:completion [Qualitative Concept]
   748   C1706386:Experiment [Conceptual Entity]
   714   C1698986:Store [Functional Concept]
Processing 00000000.tx.64: They were then thawed and boiled for 3min. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "thawed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]

Phrase: "and"

Phrase: "boiled for 3min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]
Processing 00000000.tx.65: Proteins were resolved on a 10% w/v SDS gel and visualized by staining with Coomassie Blue. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved on a 10% w/v SDS gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0231966:V A [Clinical Attribute]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C1382104:Gel [Substance]
   744   C1514893:Resolved [Idea or Concept]
   744   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "visualized by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with Coomassie Blue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   861   C1260957:Blue [Qualitative Concept]
Processing 00000000.tx.66: The density of the complex band was determined by densitometry scanning with the data being analyzed by a semilog plot against time using the software Quantity One (Bio-Rad). 

Phrase: "The density of the complex band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "determined by densitometry scanning"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0011321:densitometric scanning [Laboratory Procedure]
           Densitometry
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]

Phrase: "with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "being"

Phrase: "analyzed by a semilog plot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0936012:Analyzed [Research Activity]

Phrase: "against time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the software Quantity One (Bio-Rad"

Phrase: ")."
Processing 00000000.tx.67: Determination of the Reaction Parameters Describing tPA Inhibition-- Inhibition rate constants (ka and kd) for the inhibition of tPA by NS or NS(S49P) were determined under pseudo-first order conditions, i.e. 

Phrase: "Determination of the Reaction Parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]

Phrase: "Describing"

Phrase: "tPA Inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   756   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   741 E C0311403:Inhibited [Qualitative Concept]

Phrase: "--"

Phrase: "Inhibition rate constants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C2986811:Rate Constant [Quantitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]

Phrase: "(ka"

Phrase: "and"

Phrase: "kd) for the inhibition of tPA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0026691:KD [Disease or Syndrome]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]

Phrase: "by NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "determined under pseudo-first order conditions,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C1373201:First Order [Functional Concept]
   753   C0205237:Pseudo [Qualitative Concept]
   753   C0205435:First [Quantitative Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.68: [I]10[E]0, using the progress-curve method (41, 42). 

Phrase: "[I]10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "[E]0,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the progress-curve method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.69: Rate constants of inhibition were measured at 25 C in inhibition buffer (50mM Hepes, 150mM NaCl, 0.01% w/v dodecyl-maltoside, pH 7.4) by adding tPA (20nM) to a mixture of NS (from 200to 1000nM) or NS(S49P) (2000nM) and the substrate S-2288 (1mM) and recording the release of product as a function of time. 

Phrase: "Rate constants of inhibition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C2986811:Rate Constant [Quantitative Concept]
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]
   737   C1547014:*Constant [Quantitative Concept]
   737   C1948059:Constant [Qualitative Concept]

Phrase: "were"

Phrase: "measured at 25 C in inhibition buffer"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0444706:Measured [Qualitative Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "(50mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.01% w/v dodecyl-maltoside,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0058629:dodecyl maltoside [Carbohydrate,Pharmacologic Substance]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "by adding tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "(20nM"

Phrase: ")"

Phrase: "to a mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "("

Phrase: "from 200to 1000nM"

Phrase: ")"

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(2000nM"

Phrase: ")"

Phrase: "and"

Phrase: "the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "S-"

Phrase: "2288"

Phrase: "(1mM"

Phrase: ")"

Phrase: "and"

Phrase: "recording"

Phrase: "the release of product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.70: The progress curves were analyzed according to Equation1 (42, 43): (Eq.1) where vz is the initial velocity, vs is the steady-state velocity at completion of the reaction, and kobs is the pseudo-first order rate constant for the approach to the steady state. 

Phrase: "The progress curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "analyzed according to Equation1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0680240:according [Social Behavior]
   770   C0936012:Analyzed [Research Activity]

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: ":"

Phrase: "(Eq.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:EQ [Qualitative Concept]
   861   C0439185:Eq [Quantitative Concept]

Phrase: ")"

Phrase: "where vz"

Phrase: "is"

Phrase: "the initial velocity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205265:Initial [Temporal Concept]
   861   C0439830:Velocity [Quantitative Concept]
   861   C1279901:Initial [Qualitative Concept]
   861   C1547053:*Velocity [Quantitative Concept]
   861   C1555582:Initial [Idea or Concept]
   861   C1705685:INITIAL [Functional Concept]

Phrase: "vs"

Phrase: "is"

Phrase: "the steady-state velocity at completion of the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439830:Velocity [Quantitative Concept]
   742   C1547053:*Velocity [Quantitative Concept]

Phrase: "and"

Phrase: "kobs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0325269:Kob [Mammal]

Phrase: "is"

Phrase: "the pseudo-first order rate constant for the approach"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C1373201:First Order [Functional Concept]
   764   C2986811:Rate Constant [Quantitative Concept]
   742   C0205237:Pseudo [Qualitative Concept]
   742   C0205435:First [Quantitative Concept]
   742   C0871208:Rate [Activity]
   742   C1279901:First [Qualitative Concept]
   742   C1521828:Rate [Quantitative Concept]
   742   C1547014:*Constant [Quantitative Concept]
   742   C1705175:Order [Intellectual Product]
   742   C1705176:Order [Qualitative Concept]
   742   C1705177:Order [Classification]
   742   C1705178:Order [Activity]
   742   C1882348:Order [Qualitative Concept]
   742   C1948059:Constant [Qualitative Concept]

Phrase: "to the steady state."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678587:steady state [Natural Phenomenon or Process]
   861   C0205361:Steady [Qualitative Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.71: The values for the different variables were obtained by fitting the progress curve to Equation1 using nonlinear regression analysis and were used to calculate ka according to Equation2 assuming that the inhibition conforms to a simple bimolecular reaction (42, 43) (Eq.2) where Km of S-2288 at 25C in the inhibition buffer was 1.2mM (0.1) as measured independently. 

Phrase: "The values for the different variables"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by fitting"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0036572:Fitting [Sign or Symptom]
   790   C0441548:Fitting [Health Care Activity]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the progress curve to Equation1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205134:Curve [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nonlinear regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "ka according to Equation2"

Phrase: "assuming"

Phrase: "that"

Phrase: "the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "conforms to a simple bimolecular reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205352:Simple [Qualitative Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: "(Eq.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:EQ [Qualitative Concept]
   861   C0439185:Eq [Quantitative Concept]

Phrase: ")"

Phrase: "where Km of S-2288 at 25C"

Phrase: "in the inhibition buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "1.2mM"

Phrase: "(0.1"

Phrase: ")"

Phrase: "as"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "independently."
Processing 00000000.tx.72: The final kinetic parameters are the meanS.D. of at least three experiments. 

Phrase: "The final kinetic parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0449381:Parameters [Finding]
   793 E C0549193:Parameter [Spatial Concept]
   793 E C1704769:Parameter [Conceptual Entity]
   793 E C2350001:Parameter [Quantitative Concept]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of"

Phrase: "at least three experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.73: Circular Dichroism-- Circular dichroism (CD) experiments were performed using a JASCO J-810 spectropolarimeter in buffer (50mM Tris-HCl, 50mM KCl, pH 7.4). 

Phrase: "Circular Dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "--"

Phrase: "Circular dichroism (CD) experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a JASCO J-810 spectropolarimeter in buffer"

Phrase: "(50mM Tris-HCl,"

Phrase: "50mM KCl,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.74: Changes in the secondary structure of NS or NS(S49P) with time and temperature were measured by monitoring the CD signal at 216nm for 24h with protein concentrations between 0.5and 1mg/ml. 

Phrase: "Changes in the secondary structure of NS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "with time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "were"

Phrase: "measured by monitoring"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0150369:Monitoring [Health Care Activity]
   790   C0444706:Measured [Qualitative Concept]
   790   C1516647:monitoring [Research Activity]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the CD signal at 216nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "with protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "between 0.5and 1mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.75: The data were fitted to single or double exponential functions. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "fitted to single"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0036572:Fit [Sign or Symptom]
   790   C0037179:Single [Population Group]
   790   C0087136:single [Finding]
   790   C0205171:Single [Quantitative Concept]
   790   C0424576:Fit [Finding]
   790   C2349186:Fit [Activity]

Phrase: "or"

Phrase: "double exponential functions."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   884   C2986953:Exponential Function [Quantitative Concept]
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.76: Thermal unfolding experiments were performed by monitoring the CD signal at 216or 222nm between 25and 95C using a heating rate of 1C/min at a concentration of 0.5or 1mg/ml. 

Phrase: "Thermal unfolding experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed by monitoring"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0150369:Monitoring [Health Care Activity]
   790   C0884358:Performed [Functional Concept]
   790   C1516647:monitoring [Research Activity]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the CD signal at 216or 222nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "between 25and 95C"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a heating rate of 1C/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.5or 1mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.77: Melting points (Tm) were calculated using an expression for a two-state transition as described previously (44, 45). 

Phrase: "Melting points"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C1881775:Melting Point [Natural Phenomenon or Process]
   861   C0599882:Melting [Natural Phenomenon or Process]
   827 E C0050572:MELT [Therapeutic or Preventive Procedure]
   827 E C1540179:MELT [Gene or Genome]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "(Tm)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3540468:TM [Gene or Genome]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an expression for a two-state transition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.78: The results are the average of three experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the average of three experiments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.79: Polymerization of NS and NS(S49P)-- Polymerization of NS and NS(S49P) was assessed by nondenaturing PAGE in buffer (50mM Tris-HCl, 50mM KCl, pH 7.4). 

Phrase: "Polymerization of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "--"

Phrase: "Polymerization of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "was"

Phrase: "assessed by nondenaturing PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "in buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50mM Tris-HCl,"

Phrase: "50mM KCl,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.80: NS or NS(S49P) were incubated at a concentration ranging from 0.25to 1mg/ml at a temperature from 4to 45C. 

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "incubated at a concentration ranging"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0086045:Concentration [Mental Process]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1446561:Concentration [Quantitative Concept]
   726   C1514721:Range [Quantitative Concept]
   726   C2348147:Range [Quantitative Concept]
   726   C3542016:Range [Intellectual Product]

Phrase: "from 0.25to 1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: "at a temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "from 4to 45C."
Processing 00000000.tx.81: Aliquots were taken overtime, and 2g of protein were loaded on a 7.5% w/v nondenaturing gel. 

Phrase: "Aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "overtime,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2961731:Overtime [Pharmacologic Substance]

Phrase: "and"

Phrase: "2g of protein"

Phrase: "were"

Phrase: "loaded on a 7.5% w/v nondenaturing gel."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   762   C0231966:V A [Clinical Attribute]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C1382104:Gel [Substance]
   742   C1708715:Loaded [Activity]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.82: The proteins were visualized by staining with Coomassie Blue or by silver staining. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with Coomassie Blue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   861   C1260957:Blue [Qualitative Concept]

Phrase: "or by silver staining."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.83: Peptide Insertion-- NS or NS(S49P) were incubated for 24h at 0.5mg/ml in the presence of a 100-fold molar excess of a 6-mer peptide corresponding to the P7-P2 region of the reactive center loop of 1-antitrypsin or a 12-mer peptide corresponding to the P14-P3 region of the reactive center loop of antithrombin. 

Phrase: "Peptide Insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "--"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "at 0.5mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a 100-fold molar excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1979886:Excess [Qualitative Concept]

Phrase: "of a 6-mer peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to the P7-P2 region of the reactive center loop"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0017446:Region [Geographic Area]
   738   C0205099:Center [Spatial Concept]
   738   C0205147:Region [Spatial Concept]
   738   C0205332:Reactive [Qualitative Concept]
   738   C0419518:Loop [Medical Device]
   738   C0445022:Loop [Spatial Concept]
   738   C1384585:P2 [Immunologic Factor]
   738   C1419693:P2 [Gene or Genome]
   738   C1424742:p7 [Gene or Genome]
   738   C1539372:p2 [Gene or Genome]
   718   C0558281:Regional center [Manufactured Object]

Phrase: "of 1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "or"

Phrase: "a 12-mer peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to the P14-P3 region of the reactive center loop"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   738   C0017446:Region [Geographic Area]
   738   C0205099:Center [Spatial Concept]
   738   C0205147:Region [Spatial Concept]
   738   C0205332:Reactive [Qualitative Concept]
   738   C0419518:Loop [Medical Device]
   738   C0445022:Loop [Spatial Concept]
   738   C1412751:P3 [Gene or Genome]
   738   C1427831:P3 [Gene or Genome]
   738   C1539372:p3 [Gene or Genome]
   718   C0558281:Regional center [Manufactured Object]

Phrase: "of antithrombin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003438:Antithrombin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0003440:Antithrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.84: As the polymerization of NS or NS(S49P) was fast compared with 1-antitrypsin and antithrombin, the experiments were conducted at both 37and 15C. 

Phrase: "As the polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "was"

Phrase: "fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015663:Fast [Finding]
  1000   C0456962:Fast [Qualitative Concept]

Phrase: "compared with 1-antitrypsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418544:ANTITRYPSIN [Gene or Genome]
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "antithrombin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003438:Antithrombin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C0003440:Antithrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "conducted at both 37and 15C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0004927:Conduct [Individual Behavior]
Processing 00000000.tx.85: The results were analyzed by loading the sample onto a 7.5% w/v nondenaturing gel with or without 8M urea (46). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "analyzed by loading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0936012:Analyzed [Research Activity]
   790   C1708715:Loading [Activity]

Phrase: "the sample onto a 7.5% w/v nondenaturing gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0370003:Sample [Substance]
   739   C2347026:Sample [Conceptual Entity]

Phrase: "with"

Phrase: "or without 8M urea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   715 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.86: The presence of polymers was visualized by silver staining.  

Phrase: "The presence of polymers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "visualized by silver staining."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.87: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Inhibitory Activity of NS and NS(S49P)-- The progress curve for wild-type neuroserpin did not reach a plateau, but the absorbance steadily increased with time. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitory Activity of NS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "-"

Phrase: "-"

Phrase: "The progress curve for wild-type neuroserpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205134:Curve [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "a plateau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2964353:Plateau [Quantitative Concept]

Phrase: "but"

Phrase: "the absorbance steadily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1268822:Absorbance [Clinical Attribute]
   861   C2825050:Absorbance [Phenomenon or Process]

Phrase: "increased with time."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   718 E C1517378:Gain [Quantitative Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.88: This indicates that the mechanism of inhibition is reversible, or that the enzyme adsorbs to the walls of the spectrophotometer cuvette and thus escapes inhibition (47). 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the mechanism of inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "reversible,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "or"

Phrase: "that"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "adsorbs to the walls of the spectrophotometer cuvette"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0180266:cuvette [Medical Device]
   744   C0183400:Spectrophotometer [Medical Device]
   744   C0677535:Walls [Manufactured Object]

Phrase: "and"

Phrase: "thus"

Phrase: "escapes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870509:escape [Mental Process]
  1000   C1880554:ESCAPE [Event]

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.89: However, the value of vs was reproducible for a fixed inhibitor concentration, and the profile of vs versus [I] was hyperbolic and fitted well to a classical, fully competitive inhibition mechanism. 

Phrase: "However,"

Phrase: "the value of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522609:Value [Quantitative Concept]

Phrase: "vs"

Phrase: "was"

Phrase: "reproducible for a fixed inhibitor concentration,"

Phrase: "and"

Phrase: "the profile of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1979963:Profile [Laboratory Procedure]
   790   C2003903:Profile [Functional Concept]

Phrase: "vs"

Phrase: "versus"

Phrase: "[I]"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "hyperbolic"

Phrase: "and"

Phrase: "fitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "well to a classical, fully competitive inhibition mechanism."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0301626:Competitive inhibition [Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0205170:Well [Qualitative Concept]
   744   C0439858:Classical [Qualitative Concept]
   744   C0441712:Mechanism [Functional Concept]
   744   C0443177:Classical [Functional Concept]
   744   C0679932:competitive [Social Behavior]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1706376:Mechanism [Manufactured Object]
   744   C3146287:Well [Manufactured Object]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.90: The progressive increase in absorbance can therefore be attributed to the dissociation of the complex. 

Phrase: "The progressive increase in absorbance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "can"

Phrase: "therefore"

Phrase: "be"

Phrase: "attributed to the dissociation of the complex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.91: This allowed calculation of the dissociation and association rate constants from Equation2. 

Phrase: "This allowed calculation of the dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1441506:Calculation [Activity]

Phrase: "and"

Phrase: "association rate constants from Equation2."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   773   C2986811:Rate Constant [Quantitative Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   726   C1547014:*Constant [Quantitative Concept]
   726   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.92: The apparent pseudo-first order rate constant kobs increased linearly with the NS concentration up to 1M (Fig. 1A). 

Phrase: "The apparent pseudo-first order rate constant kobs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0325269:Kob [Mammal]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "linearly with the NS concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086045:Concentration [Mental Process]
   760   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1418546:NEUROSERPIN [Gene or Genome]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "up to 1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.93: Within this concentration range, the mechanism of inhibition of tPA by NS is consistent with a one-step reaction (41). 

Phrase: "Within this concentration range,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "the mechanism of inhibition of tPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "by NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "is"

Phrase: "consistent with a one-step reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.94: A ka value of 1.2104 M1s1 and a kd value of 7105 s1 were calculated by regression analysis of the data using Equation1 (Table I). 

Phrase: "A ka value of 1.2104 M1s1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "a kd value of 7105 s1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0026691:KD [Disease or Syndrome]
   753   C1522609:Value [Quantitative Concept]
   753   C1705240:KD [Gene or Genome]
   753   C1839259:KD [Disease or Syndrome]

Phrase: "were"

Phrase: "calculated by regression analysis of the data"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0034980:Regression Analysis [Intellectual Product]
   774   C0010992:Data Analysis [Occupational Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0444686:Calculated [Functional Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C0936012:Analysis [Research Activity]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]
   748   C1511726:Data [Idea or Concept]
   748   C1524024:analysis [Functional Concept]
   748   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Equation1"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.95: View larger version (11K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.97: Inhibition of tPA by NS or NS(S49P) at pH 7.4and 25C. 

Phrase: "Inhibition of tPA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at pH 7.4and 25C."
Processing 00000000.tx.98: A, the effect of NS on kobs, the pseudo-first order constant of tPA inhibition in the presence of 20nM tPA. 

Phrase: "A,"

Phrase: "the effect of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on kobs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0325269:Kob [Mammal]

Phrase: "the pseudo-first order constant of tPA inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1547014:*Constant [Quantitative Concept]
   739   C1948059:Constant [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 20nM tPA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.99: The theoretical curve has been calculated using Equation2 and the best estimates of ka and kd. 

Phrase: "The theoretical curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Equation2"

Phrase: "and"

Phrase: "the best estimates of ka"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441495:Best estimate [Laboratory Procedure]
   760   C0750572:estimates [Quantitative Concept]

Phrase: "and"

Phrase: "kd."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.100: B, a typical progress curve for the inhibition of tPA at 20nM by NS(S49P) at 2M.  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a typical progress curve for the inhibition of tPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205134:Curve [Spatial Concept]

Phrase: "at 20nM"

Phrase: "by NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 2M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]
Processing 00000000.tx.101: View this table: [in this window] [in a new window]  Table I Kinetic constants for the inhibition of tPA by NS and NS(S49P) at 25C and pH 7.4 The errors on the kinetic parameters ka and kd are <10 and <20% for Ki. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Kinetic constants for the inhibition of tPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1547014:*Constant [Quantitative Concept]
   704   C1948059:Constant [Qualitative Concept]

Phrase: "by NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 25C"

Phrase: "and"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "The errors on the kinetic parameters ka"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0743559:errors [Qualitative Concept]
   714 E C1608199:Error [Functional Concept]

Phrase: "and"

Phrase: "kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "are <"

Phrase: "10"

Phrase: "and <"

Phrase: "20% for Ki."
Processing 00000000.tx.102: The results are the meanS.D. of three experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of three experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.103: The incubation of mutant NS(S49P) with tPA also resulted in a progress curve that did not reach a plateau (Fig. 1B). 

Phrase: "The incubation of mutant NS"

Phrase: "(S49P"

Phrase: ")"

Phrase: "with tPA also"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "resulted in a progress"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1272688:progress [Functional Concept]
   770   C1280477:Progress [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "a plateau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2964353:Plateau [Quantitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: The progress curve clearly shows a pre-steady-state release of product followed by a steady state, but in addition there is an increase in the rate of substrate hydrolysis. 

Phrase: "The progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]

Phrase: "clearly"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a pre-steady-state release of product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "followed by a steady state,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C0678587:steady state [Natural Phenomenon or Process]
   760   C0205361:Steady [Qualitative Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "but in addition there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1883712:Addition [Functional Concept]

Phrase: "is"

Phrase: "an increase in the rate of substrate hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]
Processing 00000000.tx.105: The first derivative of the data indeed shows an increase in the rate of hydrolysis after 30min (data not shown). 

Phrase: "The first derivative of the data indeed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1527240:Derivative [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an increase in the rate of hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "after 30min"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: We were not able to follow the inhibition of tPA by NS(S49P) at the lowest concentration used for its inhibition by NS, and therefore, the rate constants kd and ka were only determined at a NS(S49P) concentration of 2M. 

Phrase: "We"

Phrase: "were"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "the inhibition of tPA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at the lowest concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used for its inhibition"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1273517:used [Finding]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "by NS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "therefore,"

Phrase: "the rate constants kd"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0026691:KD [Disease or Syndrome]
   827   C1705240:KD [Gene or Genome]
   827   C1839259:KD [Disease or Syndrome]
   701   C2986811:Rate Constant [Quantitative Concept]

Phrase: "and"

Phrase: "ka"

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "determined at a NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "concentration of 2M."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086045:Concentration [Mental Process]
   790   C1446561:Concentration [Quantitative Concept]
   718 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.107: Because of the increase in the rate of hydrolysis of the substrate after 30min, the first 30min of the progress curve were used to determined the kinetic constants. 

Phrase: "Because of the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "of the substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "after 30min,"

Phrase: "the first 30min of the progress curve"

Phrase: "were"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "determined"

Phrase: "the kinetic constants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.108: We calculated values of 0.3104 M1s1 and 1.6103 s1 for ka and kd, respectively (Table I). 

Phrase: "We"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "values of 0.3104 M1s1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "1.6103 s1 for ka"

Phrase: "and"

Phrase: "kd,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "respectively"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.109: Stability of Complexes-- The stability of the neuroserpin-tPA complex was also assessed by SDS-PAGE. 

Phrase: "Stability of Complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205360:Stability [Qualitative Concept]
   790   C2347098:Stability [Qualitative Concept]
   718 E C1547311:Stable [Intellectual Product]

Phrase: "-"

Phrase: "-"

Phrase: "The stability of the neuroserpin-tPA complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205360:Stability [Qualitative Concept]
   742   C2347098:Stability [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "assessed by SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1516048:Assessed [Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.110: NS forms an SDS-stable complex (Fig. 2A) as has been reported previously (18). 

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an SDS-stable complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.111: After formation of the complex and inhibition of free tPA by 1,5-dansyl-Glu-Gly-Arg-chloromethylketone, there is the appearance of reactive loop-cleaved NS over time. 

Phrase: "After formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "inhibition of free tPA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5-dansyl-Glu-Gly-Arg-chloromethylketone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   947   C0057126:dansyl-Glu-Gly-Arg-chloromethyl ketone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "there"

Phrase: "is"

Phrase: "the appearance of reactive loop-cleaved NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0233426:Appearance [Organism Attribute]
   748   C0700364:Appearance [Qualitative Concept]

Phrase: "over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.112: This demonstrates dissociation of the covalent complex. 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "dissociation of the covalent complex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]
Processing 00000000.tx.113: The small amount of cleaved NS at the earliest time point in Fig. 

Phrase: "The small amount of cleaved NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "at the earliest time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.114: 2A, lane 2, shows that the substrate pathway has only a minor effect on the turnover of wild-type NS. 

Phrase: "2A,"

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the substrate pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor effect on the turnover of wild-type NS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.115: Densitometric analysis of the SDS-PAGE gel allowed the calculation of a kd for the NStPA complex of 1104 s1, a value comparable with that determined by direct measurement (Fig. 2B). 

Phrase: "Densitometric analysis of the SDS-PAGE gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the calculation of a kd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441506:Calculation [Activity]

Phrase: "for the NStPA complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "of 1104 s1,"

Phrase: "a value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "comparable with that"

Phrase: "determined by direct measurement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242485:Measurement [Functional Concept]
   770   C0439851:Direct [Qualitative Concept]
   770   C1947931:Direct [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.116: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.118: 10% w/v SDS-PAGE to assess the complex formed between tPA and NS or NS(S49P). 

Phrase: "10% w/v SDS-PAGE to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   799   C1704732:Page [Intellectual Product]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "formed between tPA"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   862   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   806   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0040300:Tissue [Tissue]
   760   C0205431:Formed [Functional Concept]
   760   C1367553:PLASMINOGEN [Gene or Genome]
   760   C1547928:Tissue [Intellectual Product]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")."
Processing 00000000.tx.119: A, dissociation of the NStPA complex at a 2:1 molar ratio at 25C. 

Phrase: "A,"

Phrase: "dissociation of the NStPA complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "at a 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1 molar ratio at 25C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2825550:Molar Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.120: Lane 1, NS; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.121: lanes 2-14 correspond to 1-,5-,15-,30-,60-,90-,120-,150-,180-,240-,300-, 360-, and 480-min time points; 

Phrase: "lanes 2-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "correspond to 1-,"

Phrase: "5-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15-,"

Phrase: "30-,"

Phrase: "60-,"

Phrase: "90-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "120-,"

Phrase: "150-,"

Phrase: "180-,"

Phrase: "240-,"

Phrase: "300-,"

Phrase: "360-,"

Phrase: "and"

Phrase: "480-min time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   779   C1552961:Point [Quantitative Concept]
   779   C2347617:point [Quantitative Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.122: lane 15, tPA. 

Phrase: "lane 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "tPA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.123: Lanes 1-14 contain 2g of neuroserpin, and lanes 2-15 contain 2g of tPA. 

Phrase: "Lanes 1-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "2g of neuroserpin,"

Phrase: "and"

Phrase: "lanes 2-15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "2g of tPA."
Processing 00000000.tx.124: The native reactive center loop cleaved and complex (cpx) bands are shown. 

Phrase: "The native reactive center loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205099:Center [Spatial Concept]
   812   C0205332:Reactive [Qualitative Concept]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "and"

Phrase: "complex (cpx) bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.125: B, the fractional loss (ln(fxn)) of density of the complex bands on the SDS gel was plotted against time to calculate a kd of 1104s1. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the fractional loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "(ln(fxn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414812:FXN [Gene or Genome]

Phrase: ")"

Phrase: ")"

Phrase: "of density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of the complex bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "on the SDS gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "plotted against time to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "a kd of 1104s1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026691:KD [Disease or Syndrome]
   770   C1705240:KD [Gene or Genome]
   770   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.126: C, the formation of the NS(S49P)tPA complex over a range of molar ratios. 

Phrase: "C,"

Phrase: "the formation of the NS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "tPA complex over a range of molar ratios."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0439855:Complex [Qualitative Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.127: Lane 1, molecular mass markers; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.128: lanes 2-8 correspond to NS(S49P):tPA ratios of 1,2,3,4,6,8,and 12,respectively; 

Phrase: "lanes 2-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "correspond to NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ":"

Phrase: "tPA ratios of 1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "6,"

Phrase: "8,"

Phrase: "and"

Phrase: "12,"

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.129: lane 9, NS(S49P); 

Phrase: "lane 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.130: lane 10, tPA. 

Phrase: "lane 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "tPA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.131: Lane 9contains 2g of NS, and lane 10contains 2g of tPA. 

Phrase: "Lane 9contains 2g of NS,"

Phrase: "and"

Phrase: "lane 10contains 2g of tPA."
Processing 00000000.tx.132: NS(S49P) and tPA were incubated for 3min at 25C prior to the addition of 1,5-dansyl-Glu-Gly-Arg-chloromethylketone and then incubated for an additional minute. 

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "incubated for 3min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 25C"

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5-dansyl-Glu-Gly-Arg-chloromethylketone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   947   C0057126:dansyl-Glu-Gly-Arg-chloromethyl ketone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for an additional minute."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0439232:minute [Temporal Concept]
   760   C0700321:minute [Quantitative Concept]
   760   C0702093:/minute [Temporal Concept]
   760   C1282918:Minute [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]
   760   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.133: Loading buffer was then added, and the samples were heated and assessed by 10% w/v SDS-PAGE. 

Phrase: "Loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "heated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "assessed by 10% w/v SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   748   C1516048:Assessed [Activity]
   748   C1704732:Page [Intellectual Product]
Processing 00000000.tx.134: The complex formed between NS(S49P) and tPA more readily favors the substrate pathway. 

Phrase: "The complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "formed between NS"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0205431:Formed [Functional Concept]
   790   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1418546:NEUROSERPIN [Gene or Genome]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "tPA more readily"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   884   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   840   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0040300:Tissue [Tissue]
   804   C1367553:PLASMINOGEN [Gene or Genome]
   804   C1547928:Tissue [Intellectual Product]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the substrate pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.135: The analysis of the gel is complicated by the fact that the Ki describing the interaction between NS(S49P) and tPA is high (~0.5 M) as determined kinetically. 

Phrase: "The analysis of the gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "complicated by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231242:Complicated [Functional Concept]

Phrase: "that"

Phrase: "the Ki"

Phrase: "describing"

Phrase: "the interaction between NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(~0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "M)"

Phrase: "as"

Phrase: "determined"

Phrase: "kinetically."
Processing 00000000.tx.136: Even at a 12-fold molar excess of inhibitor, the dissociation process is not negligible (t1/2 dissociation=~7 min). 

Phrase: "Even at a 12-fold molar excess of inhibitor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0026367:Molar [Body Part, Organ, or Organ Component]
   742   C0332462:Fold [Spatial Concept]
   742   C1880834:FOLD [Phenomenon or Process]
   742   C1979886:Excess [Qualitative Concept]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the dissociation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "not negligible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332269:Negligible [Qualitative Concept]

Phrase: "(t1/2 dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "=~7 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.137: Moreover, the complex that forms at a high ratio of NS(S49P) to tPA rapidly dissociates to give the reactive loop-cleaved protein, even if the remaining tPA activity is inhibited by 1,5-dansyl-Glu-Gly-Arg-chloromethylketone (Fig. 2C). 

Phrase: "Moreover,"

Phrase: "the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that forms at a high ratio of NS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "to tPA rapidly"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   923   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0040300:Tissue [Tissue]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "dissociates"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "the reactive loop-cleaved protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "even"

Phrase: "if"

Phrase: "the remaining tPA activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1150269:plasminogen activator activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   717   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]

Phrase: "is"

Phrase: "inhibited by 1,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "5-dansyl-Glu-Gly-Arg-chloromethylketone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   947   C0057126:dansyl-Glu-Gly-Arg-chloromethyl ketone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.138: Circular Dichroism-- The melting points for NS and NS(S49P) were measured by monitoring the change in CD signal at 216and 222nm (data not shown) while increasing the temperature at 1C/min. 

Phrase: "Circular Dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The melting points for NS"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   773   C1881775:Melting Point [Natural Phenomenon or Process]
   760   C0599882:Melting [Natural Phenomenon or Process]
   726 E C0050572:MELT [Therapeutic or Preventive Procedure]
   726 E C1540179:MELT [Gene or Genome]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "measured by monitoring"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0150369:Monitoring [Health Care Activity]
   790   C0444706:Measured [Qualitative Concept]
   790   C1516647:monitoring [Research Activity]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the change in CD signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025320:The change [Physiologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "at 216and 222nm"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "while"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the temperature at 1C/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.139: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.140: 3, A and B, show typical melting curves for NS and NS(S49P) at 216nm where the change in signal was the most pronounced. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "typical melting curves for NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 216nm where"

Phrase: "the change in signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "the most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "pronounced."
Processing 00000000.tx.141: In both cases, there was a decrease in signal, but the amplitude was very different. 

Phrase: "In both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "there"

Phrase: "was"

Phrase: "a decrease in signal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "the amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "very different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.142: The change in NS was large enough to readily calculate a Tm of 56.6(0.3)C. 

Phrase: "The change in NS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "large enough to readily"

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "a Tm of 56.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   760   C3540468:TM [Gene or Genome]

Phrase: "(0.3"

Phrase: ")"

Phrase: "C."
Processing 00000000.tx.143: The change in signal was far less at the same concentration for NS(S49P) with a calculated Tm of 49.9(1.2)C. 

Phrase: "The change in signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "far less at the same concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086045:Concentration [Mental Process]
   753   C0205108:far [Spatial Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "with a calculated Tm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "of 49.9"

Phrase: "(1.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "C."
Processing 00000000.tx.144: This difference in amplitude was not the result of a gross conformational transition within NS(S49P), because it had a typical serpin-unfolding transition on transverse urea gradient PAGE (Fig. 3C). 

Phrase: "This difference in amplitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the result of a gross conformational transition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "within NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "it"

Phrase: "had"

Phrase: "a typical serpin-unfolding transition"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0599156:Transition [Cell or Molecular Dysfunction]
   812   C2700061:Transition [Activity]
   741 E C1182674:Transitional [Spatial Concept]
   741 E C1548597:Transitional [Idea or Concept]

Phrase: "on transverse urea gradient PAGE (Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.145: These gels also showed that NS was more stable than NS(S49P) with an unfolding transition at ~6 M urea compared with 1M urea for the mutant protein. 

Phrase: "These gels also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "was"

Phrase: "more stable than NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205360:Stable [Qualitative Concept]
   770   C1547311:Stable [Intellectual Product]

Phrase: "(S49P"

Phrase: ")"

Phrase: "with an unfolding transition at ~6 M urea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   743 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "compared with 1M urea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0470296:1M [Quantitative Concept]
   770   C1707455:Compared [Activity]
   715 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "for the mutant protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.146: NS and NS(S49P) were also incubated at 0.25mg/ml between 4and 90C for 15min and then assessed by nondenaturing PAGE. 

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "incubated at 0.25mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439526:/mL [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "between 4and 90C"

Phrase: "for 15min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "assessed by nondenaturing PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.147: Polymers appeared between 50and 60C for NS and between 40and 50C for NS(S49P), in good agreement with the Tm calculated from the CD spectra (data not shown). 

Phrase: "Polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "appeared between 50and 60C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0700364:APPEAR [Qualitative Concept]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and between 40and 50C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ","

Phrase: "in good agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680240:Agreement [Social Behavior]

Phrase: "with the Tm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
  1000   C3540468:TM [Gene or Genome]

Phrase: "calculated from the CD spectra"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0008813:Circular Dichroism [Laboratory Procedure]
   753   C0444686:Calculated [Functional Concept]
   753   C0596436:dichroism [Natural Phenomenon or Process]
   753   C1282913:Circular [Spatial Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.149: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.150: CD signal at 216nm for NS at 1mg/ml (A) or NS(S49P) at 1mg/ml (B) at pH 7.4while increasing the sample temperature at 1C/min. 

Phrase: "CD signal at 216nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "at 1mg/ml (A)"

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 1mg/ml (B)"

Phrase: "at pH 7.4while"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1882074:pH 7 [Qualitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the sample temperature at 1C/min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.151: C, 7.5% w/v transverse urea gradient PAGE of NS (left) and NS(S49P) (right). 

Phrase: "C,"

Phrase: "7.5% w/v transverse urea gradient PAGE of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1538570:PAGE-5 [Gene or Genome]
   739   C1704732:Page [Intellectual Product]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.152: The left and right of the gel represent 0and 8M urea, respectively. 

Phrase: "The left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "and"

Phrase: "right of the gel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205090:Right [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "0and 8M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.153: Polymerization of Neuroserpin-- Differences were observed in the far-UV CD spectra between NS and NS(S49P). 

Phrase: "Polymerization of Neuroserpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "--"

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in the far-UV CD spectra"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0008813:Circular Dichroism [Laboratory Procedure]
   744   C0041625:UV [Natural Phenomenon or Process]
   744   C0205108:far [Spatial Concept]
   744   C0596436:dichroism [Natural Phenomenon or Process]
   744   C1282913:Circular [Spatial Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1961129:uV [Quantitative Concept]
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "between NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")."
Processing 00000000.tx.154: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.155: 4A shows that in their native form, the two inhibitors adopt a different configuration. 

Phrase: "4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in their native form,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0302891:Native [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "the two inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a different configuration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449830:Configuration [Spatial Concept]
   861   C2827597:Configuration [Conceptual Entity]
Processing 00000000.tx.156: The spectra for NS is very similar to the one observed for native 1-antitrypsin (48). 

Phrase: "The spectra for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1883073:Spectrum [Quantitative Concept]
   737   C2827424:Spectrum [Conceptual Entity]

Phrase: "is"

Phrase: "very similar to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "observed for native 1-antitrypsin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0302891:Native [Functional Concept]
   760   C1418544:ANTITRYPSIN [Gene or Genome]
   760   C1441672:Observed [Functional Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.157: In comparison, the CD profile for NS(S49P) was significantly more negative with an important increase in magnitude of the signal at 216nm and a less significant decrease at 222nm. 

Phrase: "In comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the CD profile for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "was"

Phrase: "significantly more negative with an important increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205160:Negative [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "in magnitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449286:magnitude [Quantitative Concept]
  1000   C1704240:Magnitude [Quantitative Concept]

Phrase: "of the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "at 216nm"

Phrase: "and"

Phrase: "a less significant decrease at 222nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.158: Spectra were also taken after polymerization at 45C for 24h. 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "taken after polymerization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0314672:Polymerisation [Phenomenon or Process]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "at 45C"

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.159: In both cases, the spectra were very similar to the one obtained for native NS(S49P) and were consistent with the formation of loop-sheet polymers as observed for 1-antitrypsin (48). 

Phrase: "In both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "very similar to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "obtained for native NS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302891:Native [Functional Concept]
   770   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1301820:Obtained [Functional Concept]
   770   C1418546:NEUROSERPIN [Gene or Genome]
   737 E C1706701:Obtain [Activity]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "consistent with the formation of loop-sheet polymers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "as"

Phrase: "observed for 1-antitrypsin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418544:ANTITRYPSIN [Gene or Genome]
   770   C1441672:Observed [Functional Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.160: This decrease in the magnitude of the signal at 216nm was followed over a period of 24h at different temperatures and used to calculate rates of polymerization (Table II). 

Phrase: "This decrease in the magnitude of the signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "at 216nm"

Phrase: "was"

Phrase: "followed over a period of 24h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0332283:followed [Temporal Concept]
   753   C0439531:/period [Temporal Concept]
   753   C0456696:/24h [Temporal Concept]
   753   C1442770:24H [Temporal Concept]
   753   C1948053:Period [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at different temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "rates of polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.161: As noted previously, the amplitude of the change was larger for NS than for NS(S49P) (Fig. 4, B and C). 

Phrase: "As"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "previously,"

Phrase: "the amplitude of the change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "larger for NS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "than"

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.162: The rate of polymerization of NS was independent of protein concentration over the range of 0.25-1 mg/ml but showed a progressive increase at higher temperatures with a maximum value of 1.32104 s1 at 45C. 

Phrase: "The rate of polymerization of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "was independent of protein concentration"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0332291:Independent of [Functional Concept]
   806   C0427716:Protein concentration [Laboratory Procedure]
   806   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0085862:Independent [Idea or Concept]
   760   C0086045:Concentration [Mental Process]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1299583:Independent [Finding]
   760   C1421478:WAS [Gene or Genome]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "over the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of 0.25-1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439294:mg ml [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "but"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a progressive increase at higher temperatures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0015967:TEMPERATURE INCREASE [Finding]
   753   C0442805:Increase [Functional Concept]

Phrase: "with a maximum value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "of 1.32104 s1"

Phrase: "at 45C."
Processing 00000000.tx.163: In comparison, the rate of polymerization at different temperatures was constant for NS(S49P) with a value that was almost 13-fold higher than that obtained for NS at 37C. 

Phrase: "In comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the rate of polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "at different temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "was"

Phrase: "constant for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1547014:*Constant [Quantitative Concept]
   790   C1948059:Constant [Qualitative Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "with a value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "almost 13-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "obtained for NS"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1301820:Obtained [Functional Concept]
   790   C1418546:NEUROSERPIN [Gene or Genome]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.164: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.165: 4.  

Phrase: "4."
Processing 00000000.tx.166: Far-UV CD spectra of native and polymeric NS and NS(S49P). 

Phrase: "Far-UV CD spectra of native"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "polymeric NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")."
Processing 00000000.tx.167: A, the far-UV CD spectra of native NS (crossed line), NS polymers (solid line), native NS(S49P) (dashed line), and NS(S49P) polymers (dotted line). 

Phrase: "A,"

Phrase: "the far-UV CD spectra of native NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1883073:Spectrum [Quantitative Concept]
   708   C2827424:Spectrum [Conceptual Entity]

Phrase: "(crossed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "NS polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   755 E C1218520:Polymeria [Plant]

Phrase: "(solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "native NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "(dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.168: Polymers were formed by incubating NS or NS(S49P) at 0.5mg/ml at 45C for 24h and were confirmed by nondenaturing PAGE. 

Phrase: "Polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "were"

Phrase: "formed by incubating NS"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205431:Formed [Functional Concept]
   770   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1418546:NEUROSERPIN [Gene or Genome]
   770   C1439852:incubating [Laboratory Procedure]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 0.5mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "at 45C"

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "were"

Phrase: "confirmed by nondenaturing PAGE."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.169: The results are the meanS.D. of three experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of three experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.170: B, the change in the CD signal at 216nm over time for NS at 0.7mg/ml at 37C (upper curve), 41C (middle curve), and 45C (lower curve). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the change in the CD signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0025320:The change [Physiologic Function]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "at 216nm"

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "at 0.7mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "at 37C"

Phrase: "(upper curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "41C"

Phrase: "(middle curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "45C"

Phrase: "(lower curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.171: C, shows the change in the CD signal at 216nm over time for NS(S49P) at 37C and 0.5mg/ml.  

Phrase: "C,"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the change in the CD signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0025320:The change [Physiologic Function]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "at 216nm"

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 37C"

Phrase: "and"

Phrase: "0.5mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.172: View this table: [in this window] [in a new window]  Table II Rate of polymerization of neuroserpin at 1mg/ml as measured by the change in CD spectra at 216nm The results are the average of three experiments and the errors are <10%. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Rate of polymerization of neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "at 1mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "as"

Phrase: "measured by the change"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1705241:Change [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in CD spectra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]
   734   C0008813:Circular Dichroism [Laboratory Procedure]

Phrase: "at 216nm"

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the average of three experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "the errors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0743559:errors [Qualitative Concept]
   966 E C1608199:Error [Functional Concept]

Phrase: "are <"

Phrase: "10%."
Processing 00000000.tx.173: The effect of temperature on the polymerization of NS and NS(S49P) was also assessed by nondenaturing PAGE (Fig. 5A). 

Phrase: "The effect of temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0871499:effect temperature [Natural Phenomenon or Process]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "assessed by nondenaturing PAGE (Fig. 5A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1516048:Assessed [Activity]
   753   C1553637:5a [Medical Device]
   753   C1704732:Page [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: Both NS and NS(S49P) readily formed polymers at 37C and 0.25mg/ml. 

Phrase: "Both NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "readily formed polymers at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "and"

Phrase: "0.25mg/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.175: However, polymers were already visible for NS(S49P) after 2h of incubation, whereas the ladder of polymers was only clearly visible for NS after 4h of incubation. 

Phrase: "However,"

Phrase: "polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "were"

Phrase: "already visible for NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205379:Visible [Qualitative Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "after"

Phrase: "2h of incubation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292425:2H [Temporal Concept]

Phrase: "whereas"

Phrase: "the ladder of polymers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0336762:Ladder [Manufactured Object]

Phrase: "was"

Phrase: "only clearly visible for NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "after 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "of incubation."
Processing 00000000.tx.176: After 24h, both NS and NS(S49P) formed high order aggregates that were stacked at the top of the gel. 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "both NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "high order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "stacked at the top of the gel."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1382104:Gel [Substance]
   748   C1704458:Top [Spatial Concept]
   714   C3272897:Stack [Spatial Concept]
Processing 00000000.tx.177: Similar results were obtained over a concentration range of 0.25to 1mg/ml. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained over a concentration range of 0.25to 1mg/ml."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   739   C0086045:Concentration [Mental Process]
   739   C0439526:/mL [Quantitative Concept]
   739   C1301820:Obtained [Functional Concept]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1514721:Range [Quantitative Concept]
   739   C2348147:Range [Quantitative Concept]
   739   C3542016:Range [Intellectual Product]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.178: Polymer formation was also assessed over a range of temperatures. 

Phrase: "Polymer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "assessed over a range of temperatures."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   767   C0457171:temperature range [Quantitative Concept]
   753   C0039476:Temperatures [Quantitative Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C1516048:Assessed [Activity]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]
   719 E C0005903:temperature [Organism Attribute]
Processing 00000000.tx.179: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 5B demonstrates that NS and NS(S49P) formed polymers at temperatures as low as 4C. 

Phrase: "5B"

Phrase: "demonstrates"

Phrase: "that NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "formed polymers at temperatures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.181: However, whereas NS formed dimers, NS(S49P) formed higher order polymers. 

Phrase: "However,"

Phrase: "whereas"

Phrase: "NS formed dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "higher order polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   721 E C1218520:Polymeria [Plant]
Processing 00000000.tx.182: View larger version (63K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(63K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.184: Polymerization of NS and NS(S49P). 

Phrase: "Polymerization of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")."
Processing 00000000.tx.185: A, NS or NS(S49P) were incubated at 37C, and 0.25mg/ml and aliquots taken over time were analyzed by 7.5% w/v nondenaturing PAGE. 

Phrase: "A,"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "incubated at 37C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "0.25mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "taken over time"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0040223:Time [Temporal Concept]
   790   C1883727:Taken [Conceptual Entity]
   790   C3541383:Time [Temporal Concept]
   756 E C1515187:Take [Health Care Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by 7.5% w/v nondenaturing PAGE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   767   C1538570:PAGE-5 [Gene or Genome]
   744   C0936012:Analyzed [Research Activity]
   744   C1704732:Page [Intellectual Product]
Processing 00000000.tx.186: Lanes 1-5 correspond to a 0-,2-,4-,6-,and 8-h incubation time for NS (lane 1) or NS(S49P) (lane 2). 

Phrase: "Lanes 1-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "correspond to a 0-,"

Phrase: "2-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-,"

Phrase: "6-,"

Phrase: "and"

Phrase: "8-h incubation time for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.187: B, the formation of NS or NS(S49P) polymers when monomeric protein was incubated for 24h at 0.5mg/ml over a range of temperatures. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the formation of NS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "when"

Phrase: "monomeric protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "at 0.5mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "over a range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of temperatures."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039476:Temperatures [Quantitative Concept]
   966 E C0005903:temperature [Organism Attribute]
Processing 00000000.tx.188: Lanes 1-5 correspond to 0,4,10,16,and 22C incubation temperatures for NS (lane 1) or NS(S49P) (lane 2). 

Phrase: "Lanes 1-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "correspond to 0,"

Phrase: "4,"

Phrase: "10,"

Phrase: "16,"

Phrase: "and"

Phrase: "22C incubation temperatures for NS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0039476:Temperatures [Quantitative Concept]
   726 E C0005903:temperature [Organism Attribute]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.189: Peptide Insertion-- Neither the 6-mer P7-P2 1-antitrypsin peptide nor the 12-mer P14-P3 antithrombin peptide prevented the polymerization of NS or NS(S49P) at 37C. 

Phrase: "Peptide Insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "Neither the 6-mer P7-P2 1-antitrypsin peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0972289:P7 peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C0965900:P2 peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "nor"

Phrase: "the 12-mer P14-P3 antithrombin peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C1451273:P3 peptide [Amino Acid, Peptide, or Protein]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the polymerization of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 37C."
Processing 00000000.tx.190: The experiments were then repeated at 15C in an attempt to reduce the rate of polymerization and hence favor the binary complex between NS and NS(S49P) and the peptide. 

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "repeated at 15C"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205341:Repeated [Functional Concept]
   756 E C1547730:Repeat [Temporal Concept]
   756 E C1705914:Repeat [Conceptual Entity]

Phrase: "in an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "reduce"

Phrase: "the rate of polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "hence"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the binary complex between NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "the peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.191: However, even at 15C there was no binary complex between the peptides and NS or NS(S49P) (Fig. 6). 

Phrase: "However,"

Phrase: "even at 15C there"

Phrase: "was"

Phrase: "no binary complex between the peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.192: We were unable to assess the effects of a 12-mer peptide corresponding to the P14-P3 region of the reactive center loop of neuroserpin because of its poor solubility. 

Phrase: "We"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effects of a 12-mer peptide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "corresponding to the P14-P3 region of the reactive center loop of neuroserpin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   735   C0017446:Region [Geographic Area]
   735   C0205099:Center [Spatial Concept]
   735   C0205147:Region [Spatial Concept]
   735   C0205332:Reactive [Qualitative Concept]
   735   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   735   C0419518:Loop [Medical Device]
   735   C0445022:Loop [Spatial Concept]
   735   C1412751:P3 [Gene or Genome]
   735   C1418546:NEUROSERPIN [Gene or Genome]
   735   C1427831:P3 [Gene or Genome]
   735   C1539372:p3 [Gene or Genome]
   713   C0558281:Regional center [Manufactured Object]

Phrase: "because of its poor solubility."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037628:Solubility [Qualitative Concept]
   789 E C1749467:soluble [Cell Component]
   789 E C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.193: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.194: 6.  

Phrase: "6."
Processing 00000000.tx.195: Peptide insertion experiments. 

Phrase: "Peptide insertion experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.196: 6-mer 1-antitrypsin and 12-mer antithrombin peptides were incubated in 100-fold molar excess with M or Z 1-antitrypsin, NS, or NS(S49P) at 15C, and the samples were loaded on a 7.5% w/v nondenaturing gel with 8M urea. 

Phrase: "6-mer 1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "and"

Phrase: "12-mer antithrombin peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "incubated in 100-fold molar excess"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0026367:Molar [Body Part, Organ, or Organ Component]
   753   C0332462:Fold [Spatial Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C1979886:Excess [Qualitative Concept]

Phrase: "with M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "Z 1-antitrypsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "NS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 15C,"

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "loaded on a 7.5% w/v nondenaturing gel"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   762   C0231966:V A [Clinical Attribute]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C1382104:Gel [Substance]
   742   C1708715:Loaded [Activity]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "with 8M urea."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   805 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.197: Lane 1, Z 1-antitrypsin; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Z 1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.198: lane 2, Z 1-antitrypsin 24h; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Z 1-antitrypsin 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456696:/24h [Temporal Concept]
   812   C1442770:24H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.199: lane 3, Z 1-antitrypsin 24h+P7-P2 1-antitrypsin 6-mer peptide; 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "Z 1-antitrypsin 24h+P7-P2 1-antitrypsin 6-mer peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   850   C0972289:P7 peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0965900:P2 peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.200: lane 4, M 1-antitrypsin; 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "M 1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.201: lane 5, M 1-antitrypsin 24h; 

Phrase: "lane 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "M 1-antitrypsin 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456696:/24h [Temporal Concept]
   812   C1442770:24H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.202: lane 6, M 1-antitrypsin 24h+P14-P3 antithrombin 12-mer peptide; 

Phrase: "lane 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "M 1-antitrypsin 24h+P14-P3 antithrombin 12-mer peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   835   C1451273:P3 peptide [Amino Acid, Peptide, or Protein]
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.203: lane 7, NS(S49P); 

Phrase: "lane 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.204: lane 8is NS(S49P) 24h; 

Phrase: "lane 8is NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.205: lane 9, NS(S49P) 24h+P7-P2 1-antitrypsin 6-mer peptide; 

Phrase: "lane 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "24h+P7-P2 1-antitrypsin 6-mer peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   878   C0972289:P7 peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   864   C0965900:P2 peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.206: lane 10is NS(S49P) 24h+P14-P3 antithrombin 12-mer peptide; 

Phrase: "lane 10is NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "24h+P14-P3 antithrombin 12-mer peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1451273:P3 peptide [Amino Acid, Peptide, or Protein]
   795   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.207: lane 11, NS; 

Phrase: "lane 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.208: lane 12, NS 24h; 

Phrase: "lane 12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.209: lane 13, NS 24h+P7-P2 1-antitrypsin 6-mer peptide; 

Phrase: "lane 13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS 24h+P7-P2 1-antitrypsin 6-mer peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C0972289:P7 peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   854   C0965900:P2 peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.210: lane 14, NS 24h+P14-P3 antithrombin 12-mer peptide. 

Phrase: "lane 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "NS 24h+P14-P3 antithrombin 12-mer peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   850   C1451273:P3 peptide [Amino Acid, Peptide, or Protein]
   793   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.211: The lower band seen with NS is probably because of a small amount of the latent conformation.  

Phrase: "The lower band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "seen with NS"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1418546:NEUROSERPIN [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "is"

Phrase: "probably because of a small amount of the latent conformation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0026377:Conformation [Spatial Concept]
   739   C0205275:Latent [Qualitative Concept]
   739   C0700321:Small [Quantitative Concept]
   739   C0750492:Probably [Idea or Concept]
   739   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.212: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The familial dementia, FENIB, is characterized by intraneuronal inclusions of mutant S49P neuroserpin (8). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The familial dementia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "FENIB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "is"

Phrase: "characterized by intraneuronal inclusions of mutant S49P neuroserpin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C3553502:Intraneuronal inclusions [Finding]
   744   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1418546:NEUROSERPIN [Gene or Genome]
   744   C1880022:Characterized [Activity]
   711   C1512693:Inclusion [Qualitative Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.213: The principal aim of this study was to assess the biochemical differences between NS and NS(S49P), in particular their ability to inhibit tPA, their overall conformation, and the rate at which they formed polymers. 

Phrase: "The principal aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1947946:Aim [Idea or Concept]
   753   C2948600:Aim [Pharmacologic Substance]
   753   C3540471:AIM [Gene or Genome]
   753   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the biochemical differences between NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ","

Phrase: "in particular"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "tPA,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "their overall conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "the rate at which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "they"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]
Processing 00000000.tx.214: Previous work has shown that NS was capable of forming an SDS-stable complex with tPA, but the results also indicated that a proportion of the inhibitor was cleaved (18). 

Phrase: "Previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "was"

Phrase: "capable of forming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "an SDS-stable complex with tPA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "but"

Phrase: "the results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "a proportion of the inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "was"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.215: It was suggested that this was because of the turnover of NS by tPA in a substrate reaction as has been described for other serpins (16, 18). 

Phrase: "It"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "was because of the turnover of NS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0031227:turnover [Quantitative Concept]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0243127:turnover [Functional Concept]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0443331:Turnover [Health Care Activity]
   748   C1418546:NEUROSERPIN [Gene or Genome]
   748   C1421478:WAS [Gene or Genome]

Phrase: "by tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "in a substrate reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "described for other serpins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036764:Serpins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1552738:described [Idea or Concept]

Phrase: "(16,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.216: However, there is evidence that cleaved NS could result from dissociation of the complex. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that cleaved NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "could"

Phrase: "result from dissociation of the complex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   753   C0439855:Complex [Qualitative Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C2825142:Result [Finding]
Processing 00000000.tx.217: Osterwalder and colleagues (13, 19) have shown the dissociation of the complex between tPA and chicken neuroserpin, which has >80% homology to human neuroserpin and an identical reactive center loop. 

Phrase: "Osterwalder"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(13,"

Phrase: "19"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the dissociation of the complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "between tPA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "chicken neuroserpin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "which"

Phrase: "has"

Phrase: ">80% homology to human neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "and"

Phrase: "an identical reactive center loop."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205099:Center [Spatial Concept]
   812   C0205332:Reactive [Qualitative Concept]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.218: Our investigations show conclusively that the generation of the reactive center loop-cleaved species of NS was mainly because of the dissociation of the NStPA complex. 

Phrase: "Our investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261322:Investigations [Health Care Activity]
   966 E C1552578:investigation [Idea or Concept]
   916 E C1517586:Investigational [Qualitative Concept]
   916 E C3245491:investigational [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "conclusively"

Phrase: "that"

Phrase: "the generation of the reactive center loop-cleaved species of NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079411:Generation [Temporal Concept]
   738   C3146294:Generation [Activity]

Phrase: "was"

Phrase: "mainly because of the dissociation of the NStPA complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.219: The progress-curve experiments also demonstrated a dissociation process and allowed us to calculate a kd of 7105 s1, close to the one determined directly from the disappearance of the complex on the gel. 

Phrase: "The progress-curve experiments also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "a dissociation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "a kd of 7105 s1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026691:KD [Disease or Syndrome]
   760   C1705240:KD [Gene or Genome]
   760   C1839259:KD [Disease or Syndrome]

Phrase: "close to the one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205447:One [Quantitative Concept]
   770   C0587267:Close [Functional Concept]

Phrase: "determined"

Phrase: "directly from the disappearance of the complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1947931:Directly [Qualitative Concept]

Phrase: "on the gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.220: This value is similar to the value determined for chicken neuroserpin and seems to indicate a general mechanism for the inhibition of neuroserpin in different species. 

Phrase: "This value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "similar to the value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "determined for chicken neuroserpin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0008051:Chicken [Bird]
   770   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0677521:Chicken [Food]
   770   C1365945:CHICKEN [Food]
   770   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "indicate"

Phrase: "a general mechanism for the inhibition of neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "in different species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.221: The rate of association ka determined by our experiments (1.2104 M1s1) was lower than the one determined previously (8104 M1s1) (18). 

Phrase: "The rate of association ka"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "determined by our experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "(1.2104 M1s1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0920274:M1S1 [Gene or Genome]
   827   C1705835:M1S1 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "lower than the one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "determined"

Phrase: "previously"

Phrase: "(8104 M1s1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0920274:M1S1 [Gene or Genome]
   861   C1705835:M1S1 [Gene or Genome]

Phrase: ")"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.222: This result may be partly attributed to the use of a recombinant protein produced in E.coli as was previously found for 1-antitrypsin where the ka was reduced 2-3-fold compared with the one obtained with 1-antitrypsin purified from plasma (41). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "partly"

Phrase: "attributed to the use of a recombinant protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   770   C1524063:Use of [Functional Concept]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1514798:recombinant [Organism]
   744   C1947944:Use [Intellectual Product]
   711   C0449234:Attribute [Idea or Concept]
   711   C1704772:Attribute [Conceptual Entity]
   711   C1882133:Attribute [Qualitative Concept]

Phrase: "produced in E.coli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0014834:E coli [Bacterium]

Phrase: "as"

Phrase: "was"

Phrase: "previously"

Phrase: "found for 1-antitrypsin where"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0150312:Found [Quantitative Concept]
   760   C1418544:ANTITRYPSIN [Gene or Genome]
   726 E C0243095:Find [Finding]

Phrase: "the ka"

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "2-3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C1519042:2-3 [Research Activity]

Phrase: "compared with the one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205447:One [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "obtained with 1-antitrypsin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1301820:Obtained [Functional Concept]
   770   C1418544:ANTITRYPSIN [Gene or Genome]
   737 E C1706701:Obtain [Activity]

Phrase: "purified from plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032105:Plasma [Body Substance]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   790   C1998793:Purified [Functional Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.223: An alternative possibility is that the previous results did not take into account the dissociation effect, thereby overestimating ka. 

Phrase: "An alternative possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the previous results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "take into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the dissociation effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "thereby"

Phrase: "overestimating"

Phrase: "ka."
Processing 00000000.tx.224: Nevertheless, NS remains a very good inhibitor of tPA in vitro with an equilibrium dissociation constant Ki in the nanomolar range (5.8nM). 

Phrase: "Nevertheless,"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "remains"

Phrase: "a very good inhibitor of tPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0032145:Plasminogen activator inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "in vitro with an equilibrium dissociation constant Ki"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]

Phrase: "in the nanomolar range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "(5.8nM"

Phrase: ")."
Processing 00000000.tx.225: It is not clear whether the dissociation process plays a major role in vivo, in particular in the regulation of tPA activity, because the exact amount of NS in the brain is unknown. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "the dissociation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "in particular"

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of tPA activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1150269:plasminogen activator activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]

Phrase: "because"

Phrase: "the exact amount of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.226: This is an important factor, because the yield of NS will determine the in vivo inhibition frequency, and at high concentration, the inhibition by NS could follow a two-step mechanism, leading to an overall faster inhibition of tPA (42). 

Phrase: "This"

Phrase: "is"

Phrase: "an important factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "because"

Phrase: "the yield of NS"

Phrase: "will"

Phrase: "determine"

Phrase: "the in vivo inhibition frequency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: "and at high concentration,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0086045:Concentration [Mental Process]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1446561:Concentration [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "the inhibition by NS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "could"

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "a two-step mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "leading to an overall faster inhibition of tPA"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   782   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   782   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   760   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0040300:Tissue [Tissue]
   739   C0282416:Overall [Intellectual Product]
   739   C0332152:Leading [Temporal Concept]
   739   C1367553:PLASMINOGEN [Gene or Genome]
   739   C1522538:Leading [Functional Concept]
   739   C1547928:Tissue [Intellectual Product]
   739   C1561607:Overall [Qualitative Concept]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]
   706   C0015663:Fast [Finding]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706   C0456962:Fast [Qualitative Concept]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.227: In contrast with NS, NS(S49P) showed a decrease in ka and a dramatic increase in kd with an overall increase in Ki of almost 100-fold. 

Phrase: "In contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "with NS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a decrease in ka"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "a dramatic increase in kd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "with an overall increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in Ki"

Phrase: "of almost 100-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.228: This high Ki prevented the determination of an exact stoichiometry of inhibition, because even at a concentration of NS(S49P) of 5M, the dissociation competed with the association process (t1/2 ~7 min for the dissociation and t1/2 ~1 min for the association at equimolar concentration). 

Phrase: "This high Ki"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the determination of an exact stoichiometry of inhibition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "because"

Phrase: "even at a concentration of NS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086045:Concentration [Mental Process]
   753   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1418546:NEUROSERPIN [Gene or Genome]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "of 5M,"

Phrase: "the dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "competed with the association process"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "(t1/2 ~7 min for the dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "t1/2 ~1 min for the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1301862:Min 1 [Temporal Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "at equimolar concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.229: However, the small amount of NS(S49P)tPA complex that did form as seen on SDS-PAGE (Fig. 2C), even after a relative short period of time, combined with a measurable ka by our kinetic experiments indicates that both a substrate pathway and dissociation of the complex are possible. 

Phrase: "However,"

Phrase: "the small amount of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "tPA complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
   756   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]

Phrase: "that"

Phrase: "did"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "as"

Phrase: "seen on SDS-PAGE (Fig. 2C"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0205397:Seen [Qualitative Concept]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1704732:Page [Intellectual Product]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "even after a relative short period of time,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0425946:short period [Finding]
   767   C0439564:Relative time [Temporal Concept]
   767   C0439582:Time period [Temporal Concept]
   767   C1547040:*Relative Time [Quantitative Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0439531:/period [Temporal Concept]
   744   C1282927:short [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
   744   C1806781:Short [Quantitative Concept]
   744   C1948053:Period [Temporal Concept]
   744   C2350002:Short [Quantitative Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "combined with a measurable ka"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205195:Combined [Qualitative Concept]
   760   C1513040:Measurable [Functional Concept]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "by our kinetic experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "both a substrate pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "dissociation of the complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "are"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.230: These results clearly indicate a loss of function associated with NS(S49P) and suggest that some of the symptoms of FENIB may be because of a lack of proteinase inhibitor (8). 

Phrase: "These results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "a loss of function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "associated with NS"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C1418546:NEUROSERPIN [Gene or Genome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "some of the symptoms of FENIB"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   846   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   756   C0007637:Inclusion Bodies [Cell Component]
   738   C0015576:familial [Family Group]
   738   C0085584:Encephalopathy [Disease or Syndrome]
   738   C0205392:Some [Quantitative Concept]
   738   C0241888:Familial [Functional Concept]
   738   C0242821:bodies [Human]
   738   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   738   C0683368:symptoms [Functional Concept]
   738   C1418546:NEUROSERPIN [Gene or Genome]
   738   C1457887:Symptoms [Sign or Symptom]
   738   C1512693:Inclusion [Qualitative Concept]
   738   C1963101:Encephalopathy [Finding]
   738   C1995017:Bodies [Cell Component]
   738   C3540770:Some [Intellectual Product]
   704 E C0460148:Body [Anatomical Structure]
   704 E C1268086:Body [Anatomical Structure]

Phrase: "may"

Phrase: "be because of a lack of proteinase inhibitor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   770   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C2673177:proteinase inhibitor [Molecular Function]
   767   C0377149:proteinase a [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0332268:lack [Qualitative Concept]
   744   C1622131:proteinase [Molecular Function]
   744   C1947941:Proteinase [Enzyme]
   744   C1999216:Inhibitor [Qualitative Concept]
   744   C2987476:Be [Conceptual Entity]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.231: Our results also provide strong support for the role of polymerization in the formation of the inclusions that are characteristic of FENIB (8). 

Phrase: "Our results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong support for the role of polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0183683:Support [Medical Device]
   748   C1521721:Support [Conceptual Entity]

Phrase: "in the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of the inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "characteristic of FENIB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521970:Characteristic [Qualitative Concept]
   743   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.232: The NS(S49P) mutation that underlies FENIB is in the shutter domain of the protein. 

Phrase: "The NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "underlies"

Phrase: "FENIB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "is in the shutter domain of the protein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1710078:Shutter [Manufactured Object]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.233: This region controls access of the reactive center loop to -sheet A and if perturbed will favor polymer formation (8, 48). 

Phrase: "This region controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "access of the reactive center loop to -sheet A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205099:Center [Spatial Concept]
   742   C0205332:Reactive [Qualitative Concept]
   742   C0419518:Loop [Medical Device]
   742   C0444454:Access [Spatial Concept]
   742   C0445022:Loop [Spatial Concept]
   742   C1554204:access [Idea or Concept]
   742   C2349187:Sheet [Quantitative Concept]

Phrase: "and"

Phrase: "if"

Phrase: "perturbed"

Phrase: "will"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "polymer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(8,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.234: Whereas this finding was proven by the examination of ex vivo inclusions, the polymerization of wild-type and mutant NS has never been assessed using purified protein. 

Phrase: "Whereas"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "proven by the examination of ex vivo inclusions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2348480:ex vivo [Functional Concept]
   744   C0456369:Proven [Qualitative Concept]
   744   C1515655:vivo [Spatial Concept]
   711   C1512693:Inclusion [Qualitative Concept]

Phrase: "the polymerization of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "mutant NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "has"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "been"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "purified protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.235: The polymerization rate of recombinant NS(S49P) at 37 C was 13-fold faster than NS when assessed spectroscopically (Table II). 

Phrase: "The polymerization rate of recombinant NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "(S49P"

Phrase: ")"

Phrase: "at 37 C"

Phrase: "was"

Phrase: "13-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "faster than NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "when"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "spectroscopically"

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.236: Polymerization was also apparent at lower temperatures for NS(S49P) with the formation of polymers being seen at temperatures as low as 4C (Fig. 5B). 

Phrase: "Polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "was"

Phrase: "also apparent at lower temperatures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "with the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of polymers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   893 E C1218520:Polymeria [Plant]

Phrase: "being"

Phrase: "seen at temperatures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0039476:Temperatures [Quantitative Concept]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0005903:temperature [Organism Attribute]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.237: The differences between NS and NS(S49P) were assessed by measuring melting temperature and assessing the overall conformation of the protein using CD. 

Phrase: "The differences between NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "were"

Phrase: "assessed by measuring melting temperature"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0444706:measuring [Qualitative Concept]
   760   C0449770:measuring [Quantitative Concept]
   760   C0599882:Melting [Natural Phenomenon or Process]
   760   C1516048:Assessed [Activity]
   726 E C0050572:MELT [Therapeutic or Preventive Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1540179:MELT [Gene or Genome]

Phrase: "and"

Phrase: "assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "the overall conformation of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033625:Protein Conformation [Spatial Concept]
   753   C0026377:Conformation [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]
Processing 00000000.tx.238: A comparison of the melting curve for NS and NS(S49P) showed a melting point 5C lower for NS(S49P) (Fig. 3, A and B). 

Phrase: "A comparison of the melting curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "for NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a melting point 5C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1881775:Melting Point [Natural Phenomenon or Process]

Phrase: "lower for NS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "(S49P"

Phrase: ")"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.239: An analysis of the CD spectra showed that polymers of NS and monomeric NS(S49P) have a very similar overall configuration, but that monomeric NS and NS(S49P) show striking differences. 

Phrase: "An analysis of the CD spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0037812:Spectrum Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that polymers of NS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "and"

Phrase: "monomeric NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "have"

Phrase: "a very similar overall configuration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449830:Configuration [Spatial Concept]
   812   C2827597:Configuration [Conceptual Entity]

Phrase: "but"

Phrase: "that monomeric NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "and"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "striking differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.240: This does not result from the NS(S49P) being present in the cleaved form or as denatured protein, because it had an unfolding profile on transverse urea gradient PAGE that is characteristic of a native serpin (Fig. 3C). 

Phrase: "This"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result from the NS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1274040:Result [Functional Concept]
   770   C1418546:NEUROSERPIN [Gene or Genome]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "(S49P"

Phrase: ")"

Phrase: "being"

Phrase: "present in the cleaved form"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "or as denatured protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "because"

Phrase: "it"

Phrase: "had"

Phrase: "an unfolding profile on transverse urea gradient PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "characteristic of a native serpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.241: It is likely that the reactive center loop and -sheet A in NS(S49P) are in a conformation that is intermediate between that of wild-type protein and fully formed polymers. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the reactive center loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205099:Center [Spatial Concept]
   827   C0205332:Reactive [Qualitative Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "and -"

Phrase: "sheet A in NS"

Phrase: "(S49P"

Phrase: ")"

Phrase: "are in a conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026377:Conformation [Spatial Concept]
   770   C1551058:Are [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "intermediate between that of wild-type protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205103:Intermediate [Spatial Concept]
   748   C1550465:intermediate [Idea or Concept]
   748   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "fully formed polymers."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032521:Polymers [Biomedical or Dental Material,Chemical Viewed Structurally]
   721 E C1218520:Polymeria [Plant]
Processing 00000000.tx.242: Such a conformation was predicted for Z 1-antitrypsin (and called M*) and later confirmed by our crystal structure of a shutter domain mutant of another serpin 1-antichymotrypsin (48, 49). 

Phrase: "Such"

Phrase: "a conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "was"

Phrase: "predicted for Z 1-antitrypsin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0681842:Predicted [Idea or Concept]
   760   C1418544:ANTITRYPSIN [Gene or Genome]
   760   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "M*)"

Phrase: "and"

Phrase: "later"

Phrase: "confirmed by our crystal structure of a shutter domain mutant"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   760   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   760   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   739   C0427896:Crystal [Body Substance]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C0678594:Structure [Spatial Concept]
   739   C0750484:Confirmed [Idea or Concept]
   739   C1533132:Crystal [Body Substance]
   739   C1704641:Crystal [Manufactured Object]
   739   C1710078:Shutter [Manufactured Object]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]
   706 E C1456348:Confirm [Qualitative Concept]

Phrase: "of another serpin 1-antichymotrypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443619:Antichymotrypsin [Amino Acid, Peptide, or Protein]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.243: In this conformer -sheet A was widely patent and the reactive loop partly inserted. 

Phrase: "In this conformer -sheet A"

Phrase: "was"

Phrase: "widely patent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030650:patent [Intellectual Product]
   861   C0175566:Patent [Spatial Concept]

Phrase: "and"

Phrase: "the reactive loop partly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "inserted."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]
Processing 00000000.tx.244: Thus, it is likely that the configuration of the mutant NS(S49P) is similar to that described for M* 1-antitrypsin and that this explains the differences seen on CD analysis and the ready formation of polymers in vitro and in vivo. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the configuration of the mutant NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449830:Configuration [Spatial Concept]
   753   C2827597:Configuration [Conceptual Entity]

Phrase: "(S49P"

Phrase: ")"

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "M*"

Phrase: "1-antitrypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "explains"

Phrase: "the differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "seen on CD analysis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0008813:Circular Dichroism [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205397:Seen [Qualitative Concept]
   760   C0596436:dichroism [Natural Phenomenon or Process]
   760   C0936012:Analysis [Research Activity]
   760   C1282913:Circular [Spatial Concept]
   760   C1524024:analysis [Functional Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "the ready formation of polymers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.245: The polymerization of 1-antitrypsin and other serpins can be blocked by 11-13-mer peptides that correspond to residues P14-P3 of the reactive center loop of antithrombin (30, 50-53). 

Phrase: "The polymerization of 1-antitrypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "other serpins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036764:Serpins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "blocked by 11-13-mer peptides"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0028778:Blocked [Pathologic Function]
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0332206:Blocked [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "that"

Phrase: "correspond to residues P14-P3 of the reactive center loop of antithrombin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   736   C0003438:Antithrombin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   736   C0003440:Antithrombin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0205099:Center [Spatial Concept]
   736   C0205332:Reactive [Qualitative Concept]
   736   C0419518:Loop [Medical Device]
   736   C0445022:Loop [Spatial Concept]
   736   C1412751:P3 [Gene or Genome]
   736   C1427831:P3 [Gene or Genome]
   736   C1539372:p3 [Gene or Genome]
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(30,"

Phrase: "50-53"

Phrase: ")."
Processing 00000000.tx.246: More recently, we have also demonstrated that the conformation of M* in Z 1-antitrypsin can be specifically targeted using a 6-mer peptide corresponding to residues P7-P2 of the reactive loop that anneals to the lower part of -sheet A (46). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the conformation of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026377:Conformation [Spatial Concept]

Phrase: "M* in Z 1-antitrypsin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0072348:Antitrypsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1418544:ANTITRYPSIN [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "specifically"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 6-mer peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to residues P7-P2 of the reactive"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205332:Reactive [Qualitative Concept]
   744   C1384585:P2 [Immunologic Factor]
   744   C1419693:P2 [Gene or Genome]
   744   C1424742:p7 [Gene or Genome]
   744   C1539372:p2 [Gene or Genome]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "that"

Phrase: "anneals to the lower part of -sheet A (46"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C1292711:Part of [Spatial Concept]
   742   C0441994:Lower [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C1709471:Part [Quantitative Concept]
   742   C2003888:Lower [Activity]
   742   C2349187:Sheet [Quantitative Concept]
   708 E C0205251:low [Qualitative Concept]
   708 E C1299352:Low [Qualitative Concept]
   708 E C1550472:low [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.247: Neither of these peptides was able to anneal to NS or NS(S49P) and prevent polymer formation. 

Phrase: "Neither of these peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C3274651:Neither [Qualitative Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0085732:Able [Organism Attribute]
   833   C1299581:Able [Finding]

Phrase: "anneal"

Phrase: "to NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "or"

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "and"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "polymer formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.248: This demonstrates that NS has more stringent requirements than other serpins for accepting exogenous reactive center loop peptides. 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "that NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "has"

Phrase: "more stringent requirements than other serpins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1514873:Requirement [Functional Concept]

Phrase: "for accepting exogenous reactive center loop peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.249: Taken together, our results strongly support the role of polymerization in the aggregation of mutant neuroserpin in the brain of individuals with FENIB. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the role of polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "of mutant neuroserpin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with FENIB."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0007637:Inclusion Bodies [Cell Component]
   795   C0015576:familial [Family Group]
   795   C0085584:Encephalopathy [Disease or Syndrome]
   795   C0241888:Familial [Functional Concept]
   795   C0242821:bodies [Human]
   795   C0332287:With [Qualitative Concept]
   795   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C1418546:NEUROSERPIN [Gene or Genome]
   795   C1512693:Inclusion [Qualitative Concept]
   795   C1705690:With [Intellectual Product]
   795   C1963101:Encephalopathy [Finding]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
   724 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.250: They also show that any NS(S49P) that does not polymerize will be a poor inhibitor of the target proteinase tPA, which may be important in the pathophysiology of FENIB.  

Phrase: "They also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "any NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "polymerize"

Phrase: "will"

Phrase: "be"

Phrase: "a poor inhibitor of the target proteinase tPA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   777   C0032145:Plasminogen activator inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   757   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   757   C2673177:proteinase inhibitor [Molecular Function]
   739   C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "important in the pathophysiology of FENIB."
Processing 00000000.tx.251: FOOTNOTES * This work was supported by the Medical Research Council (UnitedKingdom) and the Wellcome Trust (UnitedKingdom).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Medical Research Council"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0079816:Medical Research [Research Activity]
   790   C1556038:Medical Research [Professional or Occupational Group]
   783   C0035176:research supported [Quantitative Concept]
   753   C0035168:research [Research Activity]
   753   C0205476:Medical [Functional Concept]
   753   C0242481:Research [Research Activity]
   753   C1521721:Supported [Conceptual Entity]
   753   C1551807:Council [Population Group]
   719 E C0183683:Support [Medical Device]

Phrase: "(UnitedKingdom"

Phrase: ")"

Phrase: "and"

Phrase: "the Wellcome Trust"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237935:Trust [Individual Behavior]
   861   C3245466:trust [Idea or Concept]

Phrase: "(UnitedKingdom"

Phrase: ")."
Processing 00000000.tx.252: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.253: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.254: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.255: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.256: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.257: 44-1223-336825; 

Phrase: "44-1223-336825"

Phrase: ";"
Processing 00000000.tx.258: Fax: 44-1223-336827; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "44-1223-336827"

Phrase: ";"
Processing 00000000.tx.259: E-mail: db301@cam.ac.uk. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "db301@cam.ac.uk."
Processing 00000000.tx.260: Recipient of Wellcome Trust Advanced Clinical Fellowship. 

Phrase: "Recipient of Wellcome Trust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709854:Recipient [Human]

Phrase: "Advanced"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205179:Advanced [Qualitative Concept]
   966 E C0725066:Advance [Medical Device]

Phrase: "Clinical Fellowship."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015770:Fellowship [Educational Activity]
Processing 00000000.tx.261: Published, JBC Papers in Press, March 5,2002,DOI 10.1074/jbc.M200680200 2 By convention, serpin-reactive center loop residues are numbered according to the nomenclature of Schechter and Berger (54) for substrates and proteases. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "March 5,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M200680200 2 By convention,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0086047:convention [Human-caused Phenomenon or Process]
   744   C0439858:Convention [Qualitative Concept]
   744   C2348291:DOI [Classification]

Phrase: "serpin-reactive center loop residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "numbered according to the nomenclature of Schechter"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0449788:numbered [Quantitative Concept]
   748   C0600281:Nomenclature [Intellectual Product]
   748   C0680240:according [Social Behavior]
   748   C1524067:Nomenclature [Intellectual Product]
   714 E C0237753:*Number [Quantitative Concept]

Phrase: "and"

Phrase: "Berger"

Phrase: "(54"

Phrase: ")"

Phrase: "for substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "proteases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]
Processing 00000000.tx.262: The scissile bond in the serpin is denoted as P1-P1'. 

Phrase: "The scissile bond in the serpin"

Phrase: "is"

Phrase: "denoted as P1-P1'."
Processing 00000000.tx.263: Residues that are N terminus to P1 are P2, P3, and so forth, and residues C terminus to P1' are P2', P3', and so forth.  

Phrase: "Residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "N terminus to P1"

Phrase: "are"

Phrase: "P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "P3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "and"

Phrase: "so forth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037640:SO [Geographic Area]

Phrase: "and"

Phrase: "residues C terminus to P1'"

Phrase: "are"

Phrase: "P2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "P3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "and"

Phrase: "so forth."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037640:SO [Geographic Area]
Processing 00000000.tx.264: ABBREVIATIONS The abbreviations used are: FENIB, familial encephalopathy with neuroserpin inclusion bodies; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "FENIB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: "familial encephalopathy with neuroserpin inclusion bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1858680:Familial encephalopathy with neuroserpin inclusion bodies [Disease or Syndrome]
   753   C0085584:Encephalopathy [Disease or Syndrome]
   753   C1963101:Encephalopathy [Finding]

Phrase: ";"
Processing 00000000.tx.265: tPA, tissue plasminogen activator; 

Phrase: "tPA,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "tissue plasminogen activator"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0032143:Tissue Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1367601:PLASMINOGEN ACTIVATOR, TISSUE [Gene or Genome]
   901   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0040300:Tissue [Tissue]
   827   C1367553:PLASMINOGEN [Gene or Genome]
   827   C1547928:Tissue [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.266: NS, wild-type neuroserpin; 

Phrase: "NS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "wild-type neuroserpin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1418546:NEUROSERPIN [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.267: NS(S49P), mutant neuroserpin S49P.  

Phrase: "NS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0391188:neuroserpin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1418546:NEUROSERPIN [Gene or Genome]

Phrase: "(S49P"

Phrase: ")"

Phrase: ","

Phrase: "mutant neuroserpin S49P."
Processing 00000000.tx.268: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.269: Lansbury, P. 

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.270: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.271: (1997) Neuron 19, 1151-1154[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuron 19,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1151-1154"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.272: Kakizuka, A. 

Phrase: "Kakizuka,"

Phrase: "A."
Processing 00000000.tx.273: (1998) Trends Genet. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.274: 14, 396-402[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "14,"

Phrase: "396-402"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.275: Tran, P. 

Phrase: "Tran,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.276: B., and Miller, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.277: J. 

Phrase: "J."
Processing 00000000.tx.278: (1999) Trends Neurosci. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.279: 22, 194-197[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "22,"

Phrase: "194-197"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.280: Carrell, R. 

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.281: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.282: A. 

Phrase: "A."
Processing 00000000.tx.283: (1997) Lancet 350, 134-138[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Lancet 350,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "134-138"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.284: Carrell, R. 

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.285: W., and Gooptu, B. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Gooptu,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.286: (1998) Curr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.287: Opin. 

Phrase: "Opin."
Processing 00000000.tx.288: Struct. 

Phrase: "Struct."
Processing 00000000.tx.289: Biol. 

Phrase: "Biol."
Processing 00000000.tx.290: 8, 799-809[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "8,"

Phrase: "799-809"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.291: Carrell, R. 

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.292: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.293: A. 

Phrase: "A."
Processing 00000000.tx.294: (2002) N. 

Phrase: "(2002"

Phrase: ")"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.295: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.296: J.Med. 

Phrase: "J.Med."
Processing 00000000.tx.297: 346, 45-53[Free FullText] 7. 

Phrase: "346,"

Phrase: "45-53"

Phrase: "[Free FullText"

Phrase: "] 7."
Processing 00000000.tx.298: Davis, R. 

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.299: L., Holohan, P. 

Phrase: "L., Holohan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.300: D., Shrimpton, A. 

Phrase: "D."

Phrase: ","

Phrase: "Shrimpton,"

Phrase: "A."
Processing 00000000.tx.301: E., Tatum, A. 

Phrase: "E.,"

Phrase: "Tatum,"

Phrase: "A."
Processing 00000000.tx.302: H., Daucher, J., Collins, G. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Daucher,"

Phrase: "J.,"

Phrase: "Collins,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.303: H., Todd, R., Bradshaw, C., Kent, P., Feiglin, D., Rosenbaum, A., Yerby, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Todd,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bradshaw,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454861:Kent [Geographic Area]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Feiglin,"

Phrase: "D."

Phrase: ","

Phrase: "Rosenbaum,"

Phrase: "A.,"

Phrase: "Yerby,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.304: S., Shaw, C. 

Phrase: "S."

Phrase: ","

Phrase: "Shaw,"

Phrase: "C."
Processing 00000000.tx.305: M., Lacbawan, F., and Lawrence, D. 

Phrase: "M."

Phrase: ","

Phrase: "Lacbawan,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lawrence,"

Phrase: "D."
Processing 00000000.tx.306: A. 

Phrase: "A."
Processing 00000000.tx.307: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.308: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.309: 155, 1901-1913[Abstract/Free FullText] 8. 

Phrase: "155,"

Phrase: "1901-1913"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.310: Davis, R. 

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.311: L., Shrimpton, A. 

Phrase: "L., Shrimpton,"

Phrase: "A."
Processing 00000000.tx.312: E., Holohan, P. 

Phrase: "E.,"

Phrase: "Holohan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.313: D., Bradshaw, C., Feiglin, D., Collins, G. 

Phrase: "D."

Phrase: ","

Phrase: "Bradshaw,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Feiglin,"

Phrase: "D."

Phrase: ","

Phrase: "Collins,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.314: H., Sonderegger, P., Kinter, J., Becker, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sonderegger,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kinter,"

Phrase: "J.,"

Phrase: "Becker,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.315: M., Lacbawan, F., Krasnewich, D., Muenke, M., Lawrence, D. 

Phrase: "M."

Phrase: ","

Phrase: "Lacbawan,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Krasnewich,"

Phrase: "D."

Phrase: ","

Phrase: "Muenke,"

Phrase: "M."

Phrase: ","

Phrase: "Lawrence,"

Phrase: "D."
Processing 00000000.tx.316: A., Yerby, M. 

Phrase: "A.,"

Phrase: "Yerby,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.317: S., Shaw, C. 

Phrase: "S."

Phrase: ","

Phrase: "Shaw,"

Phrase: "C."
Processing 00000000.tx.318: M., Gooptu, B., Elliott, P. 

Phrase: "M."

Phrase: ","

Phrase: "Gooptu,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Elliott,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.319: R., Finch, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "J."
Processing 00000000.tx.320: T., Carrell, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.321: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.322: A. 

Phrase: "A."
Processing 00000000.tx.323: (1999) Nature 401, 376-379[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 401,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "376-379"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.324: Takao, M., Benson, M. 

Phrase: "Takao,"

Phrase: "M."

Phrase: ","

Phrase: "Benson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.325: D., Murrell, J. 

Phrase: "D."

Phrase: ","

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.326: R., Yazaki, M., Piccardo, P., Unverzagt, F. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yazaki,"

Phrase: "M."

Phrase: ","

Phrase: "Piccardo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Unverzagt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.327: W., Davis, R. 

Phrase: "W., Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: L., Holohan, P. 

Phrase: "L., Holohan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.329: D., Lawrence, D. 

Phrase: "D."

Phrase: ","

Phrase: "Lawrence,"

Phrase: "D."
Processing 00000000.tx.330: A., Richardson, R., Farlow, M. 

Phrase: "A.,"

Phrase: "Richardson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443048:Richardson [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: R., and Ghetti, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.332: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.333: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.334: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.335: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.336: 59, 1070-1086[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "59,"

Phrase: "1070-1086"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.337: Bradshaw, C. 

Phrase: "Bradshaw,"

Phrase: "C."
Processing 00000000.tx.338: B., Davis, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.339: L., Shrimpton, A. 

Phrase: "L., Shrimpton,"

Phrase: "A."
Processing 00000000.tx.340: E., Holohan, P. 

Phrase: "E.,"

Phrase: "Holohan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.341: D., Rea, C. 

Phrase: "D."

Phrase: ","

Phrase: "Rea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035269:REA [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C1538631:REA [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.342: B., Fieglin, D., Kent, P., and Collins, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fieglin,"

Phrase: "D."

Phrase: ","

Phrase: "Kent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454861:Kent [Geographic Area]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Collins,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.343: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.344: (2001) Arch. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.345: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.346: 58, 1429-1434[Abstract/Free FullText] 11. 

Phrase: "58,"

Phrase: "1429-1434"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.347: Stoeckli, E. 

Phrase: "Stoeckli,"

Phrase: "E."
Processing 00000000.tx.348: T., Lemkin, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lemkin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.349: F., Kuhn, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kuhn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.350: B., Ruegg, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ruegg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: A., Heller, M., and Sonderegger, P. 

Phrase: "A.,"

Phrase: "Heller,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.352: (1989) Eur. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.353: J.

Phrase: "J."
Processing 00000000.tx.354: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.355: 180, 249-258[Abstract] 12. 

Phrase: "180,"

Phrase: "249-258"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 12."
Processing 00000000.tx.356: Osterwalder, T., Contartese, J., Stoeckli, E. 

Phrase: "Osterwalder,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Contartese,"

Phrase: "J.,"

Phrase: "Stoeckli,"

Phrase: "E."
Processing 00000000.tx.357: T., Kuhn, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.358: B., and Sonderegger, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.359: (1996) EMBO J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.360: 15, 2944-2953[Abstract] 13. 

Phrase: "15,"

Phrase: "2944-2953"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 13."
Processing 00000000.tx.361: Krueger, S. 

Phrase: "Krueger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.362: R., Ghisu, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ghisu,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.363: P., Cinelli, P., Gschwend, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cinelli,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gschwend,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.364: P., Osterwalder, T., Wolfer, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Osterwalder,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wolfer,"

Phrase: "D."
Processing 00000000.tx.365: P., and Sonderegger, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.367: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.368: 17, 8984-8996[Abstract/Free FullText] 14. 

Phrase: "17,"

Phrase: "8984-8996"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.369: Schrimpf, S. 

Phrase: "Schrimpf,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.370: P., Bleiker, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bleiker,"

Phrase: "A."
Processing 00000000.tx.371: J., Brecevic, L., Kozlov, S. 

Phrase: "J.,"

Phrase: "Brecevic,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kozlov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.372: V., Berger, P., Osterwalder, T., Krueger, S. 

Phrase: "V., Berger,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Osterwalder,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Krueger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.373: R., Schinzel, A., and Sonderegger, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schinzel,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.374: (1997) Genomics 40, 55-62[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genomics 40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439509:/40 [Temporal Concept]
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "55-62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.375: Hill, R. 

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.376: M., Parmar, P. 

Phrase: "M."

Phrase: ","

Phrase: "Parmar,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.377: K., Coates, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Coates,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.378: C., Mezey, E., Pearson, J. 

Phrase: "C., Mezey,"

Phrase: "E.,"

Phrase: "Pearson,"

Phrase: "J."
Processing 00000000.tx.379: F., and Birch, N. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Birch,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330312:Birch [Plant]
  1000   C0949931:Birch, NOS [Plant]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.380: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.381: (2000) Biochem. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.382: J. 

Phrase: "J."
Processing 00000000.tx.383: 345, 595-601[CrossRef][Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "345,"

Phrase: "595-601"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.384: Silverman, G. 

Phrase: "Silverman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.385: A., Bird, P. 

Phrase: "A.,"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.386: I., Carrell, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.387: W., Coughlin, P. 

Phrase: "W., Coughlin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.388: B., Gettins, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gettins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.389: G., Irving, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Irving,"

Phrase: "J."
Processing 00000000.tx.390: I., Lomas, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.391: A., Luke, C. 

Phrase: "A.,"

Phrase: "Luke,"

Phrase: "C."
Processing 00000000.tx.392: J., Moyer, R. 

Phrase: "J.,"

Phrase: "Moyer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.393: W., Pemberton, P. 

Phrase: "W., Pemberton,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.394: A., Remold-O'Donnell, E., Salvesen, G. 

Phrase: "A.,"

Phrase: "Remold-"

Phrase: "O'Donnell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "E.,"

Phrase: "Salvesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.395: S., Travis, J., and Whisstock, J. 

Phrase: "S."

Phrase: ","

Phrase: "Travis,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Whisstock,"

Phrase: "J."
Processing 00000000.tx.396: C. 

Phrase: "C."
Processing 00000000.tx.397: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.398: Biol. 

Phrase: "Biol."
Processing 00000000.tx.399: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.400: 276, 33293-33296[Free FullText] 17. 

Phrase: "276,"

Phrase: "33293-33296"

Phrase: "[Free FullText"

Phrase: "] 17."
Processing 00000000.tx.401: Huntington, J. 

Phrase: "Huntington,"

Phrase: "J."
Processing 00000000.tx.402: A., Read, R. 

Phrase: "A.,"

Phrase: "Read"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.403: J., and Carrell, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.404: W. 

Phrase: "W."
Processing 00000000.tx.405: (2000) Nature 407, 923-926[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 407,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "923-926"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.406: Hastings, G. 

Phrase: "Hastings,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.407: A., Coleman, T. 

Phrase: "A.,"

Phrase: "Coleman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.408: A., Haudenschild, C. 

Phrase: "A.,"

Phrase: "Haudenschild,"

Phrase: "C."
Processing 00000000.tx.409: C., Stefansson, S., Smith, E. 

Phrase: "C., Stefansson,"

Phrase: "S."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "E."
Processing 00000000.tx.410: P., Barthlow, R., Cherry, S., Sandkvist, M., and Lawrence, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Barthlow,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cherry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0330657:Cherry [Plant]
  1000   C0770609:CHERRY [Food]
  1000   C0936039:Cherry [Food]

Phrase: "S."

Phrase: ","

Phrase: "Sandkvist,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lawrence,"

Phrase: "D."
Processing 00000000.tx.411: A. 

Phrase: "A."
Processing 00000000.tx.412: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.413: Biol. 

Phrase: "Biol."
Processing 00000000.tx.414: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.415: 272, 33062-33067[Abstract/Free FullText] 19. 

Phrase: "272,"

Phrase: "33062-33067"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.416: Osterwalder, T., Cinelli, P., Baici, A., Pennella, A., Krueger, S. 

Phrase: "Osterwalder,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cinelli,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baici,"

Phrase: "A.,"

Phrase: "Pennella,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1924662:Pennella [Fungus]

Phrase: "A.,"

Phrase: "Krueger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.417: R., Schrimpf, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schrimpf,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.418: P., Meins, M., and Sonderegger, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Meins,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.419: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.420: Biol. 

Phrase: "Biol."
Processing 00000000.tx.421: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.422: 273, 2312-2321[Abstract/Free FullText] 20. 

Phrase: "273,"

Phrase: "2312-2321"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.423: Qian, Z., Gilbert, M. 

Phrase: "Qian,"

Phrase: "Z.,"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.424: E., Colicos, M. 

Phrase: "E.,"

Phrase: "Colicos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: A., Kandel, E. 

Phrase: "A.,"

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.426: R., and Kuhl, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Kuhl,"

Phrase: "D."
Processing 00000000.tx.427: (1993) Nature 361, 453-457[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 361,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "453-457"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.428: Huang, Y. 

Phrase: "Huang,"

Phrase: "Y."
Processing 00000000.tx.429: Y., Bach, M. 

Phrase: "Y.,"

Phrase: "Bach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825831:BACH [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: E., Lipp, H. 

Phrase: "E.,"

Phrase: "Lipp,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.431: P., Zhuo, M., Wolfer, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhuo,"

Phrase: "M."

Phrase: ","

Phrase: "Wolfer,"

Phrase: "D."
Processing 00000000.tx.432: P., Hawkins, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hawkins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.433: D., Schoonjans, L., Kandel, E. 

Phrase: "D."

Phrase: ","

Phrase: "Schoonjans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.434: R., Godfraind, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Godfraind,"

Phrase: "J."
Processing 00000000.tx.435: M., Mulligan, R., Collen, D., and Carmeliet, P. 

Phrase: "M."

Phrase: ","

Phrase: "Mulligan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Collen,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Carmeliet,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.436: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.437: Natl. 

Phrase: "Natl."
Processing 00000000.tx.438: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.439: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.440: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.441: 93, 8699-8704[Abstract/Free FullText] 22. 

Phrase: "93,"

Phrase: "8699-8704"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.442: Frey, U., Muller, M., and Kuhl, D. 

Phrase: "Frey,"

Phrase: "U.,"

Phrase: "Muller,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kuhl,"

Phrase: "D."
Processing 00000000.tx.443: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.444: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.445: 16, 2057-2063[Abstract] 23. 

Phrase: "16,"

Phrase: "2057-2063"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.446: Seeds, N. 

Phrase: "Seeds,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]
   944 E C1519232:Seminal [Clinical Attribute]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.447: W., Williams, B. 

Phrase: "W., Williams,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.448: L., and Bickford, P. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bickford,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.449: C. 

Phrase: "C."
Processing 00000000.tx.450: (1995) Science 270, 1992-1994[Abstract] 24. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 270,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1992-1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.451: Tsirka, S. 

Phrase: "Tsirka,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.452: E., Rogove, A. 

Phrase: "E.,"

Phrase: "Rogove,"

Phrase: "A."
Processing 00000000.tx.453: D., Bugge, T. 

Phrase: "D."

Phrase: ","

Phrase: "Bugge,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.454: H., Degen, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Degen,"

Phrase: "J."
Processing 00000000.tx.455: L., and Strickland, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.456: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.457: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.458: 17, 543-552[Abstract/Free FullText] 25. 

Phrase: "17,"

Phrase: "543-552"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.459: Wang, Y. 

Phrase: "Wang,"

Phrase: "Y."
Processing 00000000.tx.460: F., Tsirka, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tsirka,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.461: E., Strickland, S., Stieg, P. 

Phrase: "E.,"

Phrase: "Strickland,"

Phrase: "S."

Phrase: ","

Phrase: "Stieg,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.462: E., Soriano, S. 

Phrase: "E.,"

Phrase: "Soriano,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.463: G., and Lipton, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lipton,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: A. 

Phrase: "A."
Processing 00000000.tx.465: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.466: Med. 

Phrase: "Med."
Processing 00000000.tx.467: 4, 228-231[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "4,"

Phrase: "228-231"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.468: Baranes, D., Lederfein, D., Huang, Y. 

Phrase: "Baranes,"

Phrase: "D."

Phrase: ","

Phrase: "Lederfein,"

Phrase: "D."

Phrase: ","

Phrase: "Huang,"

Phrase: "Y."
Processing 00000000.tx.469: Y., Chen, M., Bailey, C. 

Phrase: "Y.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "M."

Phrase: ","

Phrase: "Bailey,"

Phrase: "C."
Processing 00000000.tx.470: H., and Kandel, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kandel,"

Phrase: "E."
Processing 00000000.tx.471: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.472: (1998) Neuron 21, 813-825[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 21,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "813-825"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.473: Berger, P., Kozlov, S. 

Phrase: "Berger,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kozlov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.474: V., Cinelli, P., Kruger, S. 

Phrase: "V., Cinelli,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kruger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: R., Vogt, L., and Sonderegger, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vogt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sonderegger,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.476: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.477: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.478: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.479: 14, 455-467[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "14,"

Phrase: "455-467"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.480: Elliott, P. 

Phrase: "Elliott,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.481: R., Stein, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.482: E., Bilton, D., Carrell, R. 

Phrase: "E.,"

Phrase: "Bilton,"

Phrase: "D."

Phrase: ","

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.484: A. 

Phrase: "A."
Processing 00000000.tx.485: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.486: Struct. 

Phrase: "Struct."
Processing 00000000.tx.487: Biol. 

Phrase: "Biol."
Processing 00000000.tx.488: 3, 910-911[Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "910-911"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.489: Sivasothy, P., Dafforn, T. 

Phrase: "Sivasothy,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dafforn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: R., Gettins, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gettins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.491: G., and Lomas, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.492: A. 

Phrase: "A."
Processing 00000000.tx.493: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.494: Biol. 

Phrase: "Biol."
Processing 00000000.tx.495: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.496: 275, 33663-33668[Abstract/Free FullText] 30. 

Phrase: "275,"

Phrase: "33663-33668"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.497: Lomas, D. 

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.498: A., Evans, D. 

Phrase: "A.,"

Phrase: "Evans,"

Phrase: "D."
Processing 00000000.tx.499: L., Finch, J. 

Phrase: "L., Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0326915:Finch [Bird]

Phrase: "J."
Processing 00000000.tx.500: T., and Carrell, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.501: W. 

Phrase: "W."
Processing 00000000.tx.502: (1992) Nature 357, 605-607[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 357,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "605-607"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.503: Lomas, D. 

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.504: A., Finch, J. 

Phrase: "A.,"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "J."
Processing 00000000.tx.505: T., Seyama, K., Nukiwa, T., and Carrell, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Seyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nukiwa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.506: W. 

Phrase: "W."
Processing 00000000.tx.507: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.510: 268, 15333-15335[Abstract/Free FullText] 32. 

Phrase: "268,"

Phrase: "15333-15335"

Phrase: "[Abstract/Free FullText"

Phrase: "] 32."
Processing 00000000.tx.511: Lomas, D. 

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.512: A., Elliott, P. 

Phrase: "A.,"

Phrase: "Elliott,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.513: R., Sidhar, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sidhar,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: K., Foreman, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Foreman,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0403173:Foreman [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: C., Finch, J. 

Phrase: "C., Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0326915:Finch [Bird]

Phrase: "J."
Processing 00000000.tx.516: T., Cox, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cox,"

Phrase: "D."
Processing 00000000.tx.517: W., Whisstock, J. 

Phrase: "W., Whisstock,"

Phrase: "J."
Processing 00000000.tx.518: C., and Carrell, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.519: W. 

Phrase: "W."
Processing 00000000.tx.520: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.521: Biol. 

Phrase: "Biol."
Processing 00000000.tx.522: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.523: 270, 16864-16870[Abstract/Free FullText] 33. 

Phrase: "270,"

Phrase: "16864-16870"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.524: Eriksson, S., Carlson, J., and Velez, R. 

Phrase: "Eriksson,"

Phrase: "S."

Phrase: ","

Phrase: "Carlson,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Velez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.525: (1986) N. 

Phrase: "(1986"

Phrase: ")"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.526: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.527: J.Med. 

Phrase: "J.Med."
Processing 00000000.tx.528: 314, 736-739[Abstract] 34. 

Phrase: "314,"

Phrase: "736-739"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 34."
Processing 00000000.tx.529: Briand, C., Kozlov, S. 

Phrase: "Briand,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kozlov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.530: V., Sonderegger, P., and Grutter, M. 

Phrase: "V., Sonderegger,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Grutter,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.531: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.532: (2001) FEBS Lett. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.533: 505, 18-22[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "505,"

Phrase: "18-22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450334:18/22 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.534: Yazaki, M., Liepnieks, J. 

Phrase: "Yazaki,"

Phrase: "M."

Phrase: ","

Phrase: "Liepnieks,"

Phrase: "J."
Processing 00000000.tx.535: J., Murrell, J. 

Phrase: "J.,"

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.536: R., Takao, M., Guenther, B., Piccardo, P., Farlow, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Takao,"

Phrase: "M."

Phrase: ","

Phrase: "Guenther,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piccardo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.537: R., Ghetti, B., and Benson, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Benson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: D. 

Phrase: "D."
Processing 00000000.tx.539: (2001) Am. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.540: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.541: 158, 227-233[Abstract/Free FullText] 36. 

Phrase: "158,"

Phrase: "227-233"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.542: Yepes, M., Sandkvist, M., Wong, M. 

Phrase: "Yepes,"

Phrase: "M."

Phrase: ","

Phrase: "Sandkvist,"

Phrase: "M."

Phrase: ","

Phrase: "Wong,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: K., Coleman, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Coleman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.544: A., Smith, E., Cohan, S. 

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "E.,"

Phrase: "Cohan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.545: L., and Lawrence, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Lawrence,"

Phrase: "D."
Processing 00000000.tx.546: A. 

Phrase: "A."
Processing 00000000.tx.547: (2000) Blood 96, 569-576[Abstract/Free FullText] 37. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Blood 96,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "569-576"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.548: Chen, Z.-L., and Strickland, S. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z.-"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.549: (1997) Cell 91, 917-925[Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 91,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "917-925"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.550: Zhou, A., Carrell, R. 

Phrase: "Zhou,"

Phrase: "A.,"

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.551: W., and Huntington, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Huntington,"

Phrase: "J."
Processing 00000000.tx.552: A. 

Phrase: "A."
Processing 00000000.tx.553: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.554: Biol. 

Phrase: "Biol."
Processing 00000000.tx.555: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.556: 276, 27541-27547[Abstract/Free FullText] 39. 

Phrase: "276,"

Phrase: "27541-27547"

Phrase: "[Abstract/Free FullText"

Phrase: "] 39."
Processing 00000000.tx.557: Zhou, A., Faint, R., Charlton, P., Dafforn, T. 

Phrase: "Zhou,"

Phrase: "A.,"

Phrase: "Faint,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039070:Faint [Sign or Symptom]
   944 E C3541349:Syncope [Amphibian]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Charlton,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dafforn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.558: R., Carrell, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.559: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.560: A. 

Phrase: "A."
Processing 00000000.tx.561: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.562: Biol. 

Phrase: "Biol."
Processing 00000000.tx.563: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.564: 276, 9115-9122[Abstract/Free FullText] 40. 

Phrase: "276,"

Phrase: "9115-9122"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.565: Renatus, M., Engh, R. 

Phrase: "Renatus,"

Phrase: "M."

Phrase: ","

Phrase: "Engh,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.566: A., Stubbs, M. 

Phrase: "A.,"

Phrase: "Stubbs,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.567: T., Huber, R., Fischer, S., Kohnert, U., and Bode, W. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fischer,"

Phrase: "S."

Phrase: ","

Phrase: "Kohnert,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Bode"

Phrase: ","

Phrase: "W."
Processing 00000000.tx.568: (1997) EMBO J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.569: 16, 4797-4805[Abstract/Free FullText] 41. 

Phrase: "16,"

Phrase: "4797-4805"

Phrase: "[Abstract/Free FullText"

Phrase: "] 41."
Processing 00000000.tx.570: Belorgey, D., and Bieth, J. 

Phrase: "Belorgey,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Bieth,"

Phrase: "J."
Processing 00000000.tx.571: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.572: (1998) Biochemistry 37, 16416-16422[CrossRef][Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "16416-16422"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.573: Bieth, J. 

Phrase: "Bieth,"

Phrase: "J."
Processing 00000000.tx.574: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.575: (1995) Method Enzymol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Method Enzymol."
Processing 00000000.tx.576: 248, 59-84[CrossRef][Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "248,"

Phrase: "59-84"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.577: Morrison, J. 

Phrase: "Morrison,"

Phrase: "J."
Processing 00000000.tx.578: F., and Walsh, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Walsh,"

Phrase: "C."
Processing 00000000.tx.579: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.580: (1988) Adv. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.581: Enzymol. 

Phrase: "Enzymol."
Processing 00000000.tx.582: Relat. 

Phrase: "Relat."
Processing 00000000.tx.583: Areas Mol. 

Phrase: "Areas Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.584: Biol. 

Phrase: "Biol."
Processing 00000000.tx.585: 61, 201-301[Medline] [OrderarticleviaInfotrieve] 44. 

Phrase: "61,"

Phrase: "201-301"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 44."
Processing 00000000.tx.586: Lawrence, D. 

Phrase: "Lawrence,"

Phrase: "D."
Processing 00000000.tx.587: A., Olson, S. 

Phrase: "A.,"

Phrase: "Olson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.588: T., Palaniappan, S., and Ginsburg, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Palaniappan,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Ginsburg,"

Phrase: "D."
Processing 00000000.tx.589: (1994) Biochemistry 33, 3643-3649[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "3643-3649"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.590: Dafforn, T. 

Phrase: "Dafforn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.591: R., Della, M., and Miller, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Della,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.592: D. 

Phrase: "D."
Processing 00000000.tx.593: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.594: Biol. 

Phrase: "Biol."
Processing 00000000.tx.595: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.596: 276, 49310-49319[Abstract/Free FullText] 46. 

Phrase: "276,"

Phrase: "49310-49319"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.597: Mahadeva, R., Dafforn, T. 

Phrase: "Mahadeva,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dafforn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.598: R., Carrell, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.599: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.600: A. 

Phrase: "A."
Processing 00000000.tx.601: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.602: Biol. 

Phrase: "Biol."
Processing 00000000.tx.603: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.604: 277, 6771-6774[Abstract/Free FullText] 47. 

Phrase: "277,"

Phrase: "6771-6774"

Phrase: "[Abstract/Free FullText"

Phrase: "] 47."
Processing 00000000.tx.605: Faller, B., Cadne, M., and Bieth, J. 

Phrase: "Faller,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cadne,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bieth,"

Phrase: "J."
Processing 00000000.tx.606: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.607: (1993) Biochemistry 32, 9230-9235[Medline] [OrderarticleviaInfotrieve] 48. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochemistry 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "9230-9235"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 48."
Processing 00000000.tx.608: Dafforn, T. 

Phrase: "Dafforn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.609: R., Mahadeva, R., Elliott, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mahadeva,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Elliott,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.610: R., Sivasothy, P., and Lomas, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sivasothy,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.611: A. 

Phrase: "A."
Processing 00000000.tx.612: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.613: Biol. 

Phrase: "Biol."
Processing 00000000.tx.614: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.615: 274, 9548-9555[Abstract/Free FullText] 49. 

Phrase: "274,"

Phrase: "9548-9555"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.616: Gooptu, B., Hazes, B., Chang, W. 

Phrase: "Gooptu,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hazes,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chang,"

Phrase: "W."
Processing 00000000.tx.617: S., Dafforn, T. 

Phrase: "S."

Phrase: ","

Phrase: "Dafforn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.618: R., Carrell, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.619: W., Read, R. 

Phrase: "W.,"

Phrase: "Read"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.620: J., and Lomas, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.621: A. 

Phrase: "A."
Processing 00000000.tx.622: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.623: Natl. 

Phrase: "Natl."
Processing 00000000.tx.624: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.625: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.626: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.627: 97, 67-72[Abstract/Free FullText] 50. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "67-72"

Phrase: "[Abstract/Free FullText"

Phrase: "] 50."
Processing 00000000.tx.628: Schulze, A. 

Phrase: "Schulze,"

Phrase: "A."
Processing 00000000.tx.629: J., Baumann, U., Knof, S., Jaeger, E., Huber, R., and Laurell, C. 

Phrase: "J.,"

Phrase: "Baumann,"

Phrase: "U.,"

Phrase: "Knof,"

Phrase: "S."

Phrase: ","

Phrase: "Jaeger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325865:Jaeger [Bird]

Phrase: "E.,"

Phrase: "Huber,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Laurell,"

Phrase: "C."
Processing 00000000.tx.630: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.631: (1990) Eur. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.632: J.

Phrase: "J."
Processing 00000000.tx.633: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.634: 194, 51-56[Abstract] 51. 

Phrase: "194,"

Phrase: "51-56"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 51."
Processing 00000000.tx.635: Bjork, I., Ylinenjarvi, K., Olson, S. 

Phrase: "Bjork,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ylinenjarvi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Olson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.636: T., and Bock, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Bock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678387:bock [Food]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.637: E. 

Phrase: "E."
Processing 00000000.tx.638: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.639: Biol. 

Phrase: "Biol."
Processing 00000000.tx.640: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.641: 267, 1976-1982[Abstract/Free FullText] 52. 

Phrase: "267,"

Phrase: "1976-1982"

Phrase: "[Abstract/Free FullText"

Phrase: "] 52."
Processing 00000000.tx.642: Fitton, H. 

Phrase: "Fitton,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.643: L., Pike, R. 

Phrase: "L., Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014878:Pike [Fish]
   861   C0522667:Pike [Manufactured Object]
   861   C0730321:PIC [Disease or Syndrome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.644: N., Carrell, R. 

Phrase: "N., Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.645: W., and Chang, W. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Chang,"

Phrase: "W."
Processing 00000000.tx.646: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.647: (1997) Biol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.648: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.649: 378, 1059-1063[Medline] [OrderarticleviaInfotrieve] 53. 

Phrase: "378,"

Phrase: "1059-1063"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 53."
Processing 00000000.tx.650: Skinner, R., Chang, W. 

Phrase: "Skinner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chang,"

Phrase: "W."
Processing 00000000.tx.651: S., Jin, L., Pei, X., Huntington, J. 

Phrase: "S."

Phrase: ","

Phrase: "Jin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "X.,"

Phrase: "Huntington,"

Phrase: "J."
Processing 00000000.tx.652: A., Abrahams, J. 

Phrase: "A.,"

Phrase: "Abrahams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:abrahams [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.653: P., Carrell, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Carrell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.654: W., and Lomas, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lomas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1018105:Lomas [Fungus]

Phrase: "D."
Processing 00000000.tx.655: A. 

Phrase: "A."
Processing 00000000.tx.656: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.657: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.658: Biol. 

Phrase: "Biol."
Processing 00000000.tx.659: 283, 9-14[CrossRef][Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "283,"

Phrase: "9-14"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.660: Schechter, I., and Berger, A. 

Phrase: "Schechter,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Berger,"

Phrase: "A."
Processing 00000000.tx.661: (1967) Biochem. 

Phrase: "(1967"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.662: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.663: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.664: Commun. 

Phrase: "Commun."
Processing 00000000.tx.665: 27, 157-162[Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "27,"

Phrase: "157-162"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

